TY  - JOUR
TI  - Stress and the brain-gut axis in functional and chronic-inflammatory gastrointestinal diseases: A transdisciplinary challenge
T2  - Psychoneuroendocrinology
J2  - Psychoneuroendocrinology
VL  - 111
PY  - 2020
DO  - 10.1016/j.psyneuen.2019.104501
SN  - 03064530 (ISSN)
AU  - Labanski, A.
AU  - Langhorst, J.
AU  - Engler, H.
AU  - Elsenbruch, S.
AD  - Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
AD  - Chair for Integrative Medicine, University of Duisburg-Essen, Essen, Germany
AD  - Clinic for Internal and Integrative Medicine, Klinikum Bamberg, Bamberg, Germany
AB  - The broad role of stress in the brain-gut axis is widely acknowledged, with implications for multiple prevalent health conditions that are characterized by chronic gastrointestinal symptoms. These include the functional gastrointestinal disorders (FGID), such as irritable bowel syndrome and functional dyspepsia, as well as inflammatory bowel diseases (IBD) like ulcerative colitis and Crohn's disease. Although the afferent and efferent pathways linking the gut and the brain are modulated by stress, the fields of neurogastroenterology and psychoneuroendocrinology (PNE)/ psychoneuroimmunology (PNI) remain only loosely connected. We aim to contribute to bringing these fields closer together by drawing attention to a fascinating, evolving research area, targeting an audience with a strong interest in the role of stress in health and disease. To this end, this review introduces the concept of the brain-gut axis and its major pathways, and provides a brief introduction to epidemiological and clinical aspects of FGIDs and IBD. From an interdisciplinary PNE/PNI perspective, we then detail current knowledge regarding the role of chronic and acute stress in the pathophysiology of FGID and IBD. We provide an overview of evidence regarding non-pharmacological treatment approaches that target central or peripheral stress mechanisms, and conclude with future directions, particularly those arising from recent advances in the neurosciences and discoveries surrounding the gut microbiota. © 2019 Elsevier Ltd
KW  - Brain-gut axis
KW  - Chronic-inflammatory bowel diseases
KW  - Functional gastrointestinal disorders
KW  - Memory
KW  - Microbiota
KW  - Psychoneuroendocrinology
KW  - Psychoneuroimmunology
KW  - Stress
KW  - Visceral pain
PB  - Elsevier Ltd
N1  - Export Date: 18 November 2019
M3  - Review
DB  - Scopus
C7  - 104501
N1  - CODEN: PSYCD
LA  - English
N1  - Correspondence Address: Elsenbruch, S.; Experimental Psychobiology & Gender Research Institute of Medical Psychology and Behavioral Immunobiology University Hospital Essen, University of Duisburg-Essen Hufelandstr. 55, Germany; email: sigrid.elsenbruch@uk-essen.de
N1  - Funding details: Deutsche Forschungsgemeinschaft, DFG
N1  - Funding details: German-Israeli Foundation for Scientific Research and Development, GIF, 316803389 – SFB 1280
N1  - Funding text 1: Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) , project number 316803389 – SFB 1280. The funding source had no role in the conception of this work, interpretation of the literature or writing of this review.
N1  - References: Agostini, A., Ballotta, D., Righi, S., Moretti, M., Bertani, A., Scarcelli, A., Sartini, A., Benuzzi, F., Stress and brain functional changes in patients with Crohn's disease: a functional magnetic resonance imaging study (2017) Neurogastroenterol. Motil., 29, pp. 1-10;
Agostini, A., Filippini, N., Benuzzi, F., Bertani, A., Scarcelli, A., Leoni, C., Farinelli, V., Campieri, M., Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls (2013) J. Behav. Med., 36, pp. 477-487;
Agostini, A., Filippini, N., Cevolani, D., Agati, R., Leoni, C., Tambasco, R., Calabrese, C., Campieri, M., Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing (2011) Inflamm. Bowel Dis., 17, pp. 1769-1777;
Allen, A.P., Hutch, W., Borre, Y.E., Kennedy, P.J., Temko, A., Boylan, G., Murphy, E., Clarke, G., Bifidobacterium longum 1714 as a translational psychobiotic: modulation of stress, electrophysiology and neurocognition in healthy volunteers (2016) Transl. Psychiatry, 6, p. e939;
Ananthakrishnan, A.N., Epidemiology and risk factors for IBD (2015) Nat. Rev. Gastroenterol. Hepatol., 12, pp. 205-217;
Ananthakrishnan, A.N., Khalili, H., Pan, A., Higuchi, L.M., de Silva, P., Richter, J.M., Fuchs, C.S., Chan, A.T., Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses’ Health Study (2013) Clin. Gastroenterol. Hepatol., 11, pp. 57-62;
Baliki, M.N., Apkarian, A.V., Nociception, pain, negative moods, and behavior selection (2015) Neuron, 87, pp. 474-491;
Bao, C., Liu, P., Liu, H., Jin, X., Shi, Y., Wu, L., Zeng, X., Wu, H., Difference in regional neural fluctuations and functional connectivity in Crohn's disease: a resting-state functional MRI study (2018) Brain Imaging Behav., 12, pp. 1795-1803;
Bao, C.H., Liu, P., Liu, H.R., Wu, L.Y., Shi, Y., Chen, W.F., Qin, W., Wu, H.G., Alterations in brain grey matter structures in patients with Crohn's disease and their correlation with psychological distress (2015) J. Crohns Colitis, 9, pp. 532-540;
Barbara, G., Cremon, C., Stanghellini, V., Inflammatory bowel disease and irritable bowel syndrome: similarities and differences (2014) Curr. Opin. Gastroenterol., 30, pp. 352-358;
Bennett, E.J., Tennant, C.C., Piesse, C., Badcock, C.A., Kellow, J.E., Level of chronic life stress predicts clinical outcome in irritable bowel syndrome (1998) Gut, 43, pp. 256-261;
Benson, S., Brinkhoff, A., Lueg, L., Roderigo, T., Kribben, A., Wilde, B., Witzke, O., Elsenbruch, S., Effects of acute systemic inflammation on the interplay between sad mood and affective cognition (2017) Transl. Psychiatry, 7, p. 1281;
Benson, S., Kattoor, J., Wegner, A., Hammes, F., Reidick, D., Grigoleit, J.S., Engler, H., Elsenbruch, S., Acute experimental endotoxemia induces visceral hypersensitivity and altered pain evaluation in healthy humans (2012) Pain, 153, pp. 794-799;
Benson, S., Siebert, C., Koenen, L.R., Engler, H., Kleine-Borgmann, J., Bingel, U., Icenhour, A., Elsenbruch, S., Cortisol affects pain sensitivity and pain-related emotional learning in experimental visceral but not somatic pain: a randomized-controlled study in healthy men and women (2019) Pain, , in press;
Benson, S., Rebernik, L., Wegner, A., Kleine-Borgmann, J., Engler, H., Schlamann, M., Forsting, M., Elsenbruch, S., Neural circuitry mediating inflammation-induced central pain amplification in human experimental endotoxemia (2015) Brain Behav. Immun., 48, pp. 222-231;
Bernstein, C.N., The brain-gut Axis and stress in inflammatory bowel disease (2017) Gastroenterol. Clin. North Am., 46, pp. 839-846;
Bernstein, C.N., Singh, S., Graff, L.A., Walker, J.R., Miller, N., Cheang, M., A prospective population-based study of triggers of symptomatic flares in IBD (2010) Am. J. Gastroenterol., 105, pp. 1994-2002;
Bitton, A., Sewitch, M.J., Peppercorn, M.A., de, B.E.M.D., Shah, S., Ransil, B., Locke, S.E., Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study (2003) Am. J. Gastroenterol., 98, pp. 2203-2208;
Blanchard, E.B., Lackner, J.M., Jaccard, J., Rowell, D., Carosella, A.M., Powell, C., Sanders, K., Kuhn, E., The role of stress in symptom exacerbation among IBS patients (2008) J. Psychosom. Res., 64, pp. 119-128;
Boeckxstaens, G., Camilleri, M., Sifrim, D., Houghton, L.A., Elsenbruch, S., Lindberg, G., Azpiroz, F., Parkman, H.P., Fundamentals of neurogastroenterology: physiology/motility - sensation (2016) Gastroenterology, 150, pp. 1292-1304;
Bonaz, B., Bazin, T., Pellissier, S., The vagus nerve at the interface of the microbiota-gut-brain axis (2018) Front. Neurosci., 12, p. 49;
Bonaz, B.L., Bernstein, C.N., Brain-gut interactions in inflammatory bowel disease (2013) Gastroenterology, 144, pp. 36-49;
Bonaz, B., Sinniger, V., Pellissier, S., Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation (2016) J. Physiol. (Paris), 594, pp. 5781-5790;
Bonaz, B., Sinniger, V., Pellissier, S., The vagus nerve in the neuro-immune axis: implications in the pathology of the gastrointestinal tract (2017) Front. Immunol., 8, p. 1452;
Bonaz, B., Sinniger, V., Pellissier, S., Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease (2017) J. Intern. Med., 282, pp. 46-63;
Botha, C., Farmer, A.D., Nilsson, M., Brock, C., Gavrila, A.D., Drewes, A.M., Knowles, C.H., Aziz, Q., Preliminary report: modulation of parasympathetic nervous system tone influences oesophageal pain hypersensitivity (2015) Gut, 64, pp. 611-617;
Broers, C., Melchior, C., Van Oudenhove, L., Vanuytsel, T., Van Houtte, B., Scheerens, C., Rommel, N., Pauwels, A., The effect of intravenous corticotropin-releasing hormone administration on esophageal sensitivity and motility in health (2017) Am. J. Physiol. Gastrointest. Liver Physiol., 312, pp. G526-G534;
Brown, E.S., Woolston, D.J., Frol, A.B., Amygdala volume in patients receiving chronic corticosteroid therapy (2008) Biol. Psychiatry, 63, pp. 705-709;
Burisch, J., Jess, T., Martinato, M., Lakatos, P.L., The burden of inflammatory bowel disease in Europe (2013) J. Crohns Colitis, 7, pp. 322-337;
Burns, G., Carroll, G., Mathe, A., Horvat, J., Foster, P., Walker, M.M., Talley, N.J., Keely, S., Evidence for local and systemic immune activation in functional dyspepsia and the irritable bowel syndrome: a systematic review (2018) Am. J. Gastroenterol., 114, pp. 429-436;
Cheifetz, A.S., Gianotti, R., Luber, R., Gibson, P.R., Complementary and alternative medicines used by patients with inflammatory bowel diseases (2017) Gastroenterology, 152. , 415-429.e415;
Chitkara, D.K., van Tilburg, M.A., Blois-Martin, N., Whitehead, W.E., Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review (2008) Am. J. Gastroenterol., 103, pp. 765-774;
Coen, S.J., Yaguez, L., Aziz, Q., Mitterschiffthaler, M.T., Brammer, M., Williams, S.C., Gregory, L.J., Negative mood affects brain processing of visceral sensation (2009) Gastroenterology, 137 (253-261), pp. e251-252. , 261;
Cohen, H., Jotkowitz, A., Buskila, D., Pelles-Avraham, S., Kaplan, Z., Neumann, L., Sperber, A.D., Post-traumatic stress disorder and other co-morbidities in a sample population of patients with irritable bowel syndrome (2006) Eur. J. Int. Med., 17, pp. 567-571;
Cramer, H., Schafer, M., Schols, M., Kocke, J., Elsenbruch, S., Lauche, R., Engler, H., Langhorst, J., Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis (2017) Aliment. Pharmacol. Ther., 45, pp. 1379-1389;
Craske, M.G., Wolitzky-Taylor, K.B., Labus, J., Wu, S., Frese, M., Mayer, E.A., Naliboff, B.D., A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations (2011) Behav. Res. Ther., 49, pp. 413-421;
Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., From inflammation to sickness and depression: when the immune system subjugates the brain (2008) Nat. Rev. Neurosci., 9, pp. 46-56;
Dickhaus, B., Mayer, E.A., Firooz, N., Stains, J., Conde, F., Olivas, T.I., Fass, R., Naliboff, B.D., Irritable bowel syndrome patients show enhanced modulation of visceral perception by auditory stress (2003) Am. J. Gastroenterol., 98, pp. 135-143;
Drossman, D.A., Hasler, W.L., Rome IV-Functional GI disorders: disorders of gut-brain interaction (2016) Gastroenterology, 150, pp. 1257-1261;
Duffy, L.C., Zielezny, M.A., Marshall, J.R., Byers, T.E., Weiser, M.M., Phillips, J.F., Calkins, B.M., Graham, S., Relevance of major stress events as an indicator of disease activity prevalence in inflammatory bowel disease (1991) Behav. Med., 17, pp. 101-110;
Elsenbruch, S., Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms (2011) Brain Behav. Immun., 25, pp. 386-394;
Elsenbruch, S., Enck, P., Placebo effects and their determinants in gastrointestinal disorders (2015) Nat. Rev. Gastroenterol. Hepatol., 12, pp. 472-485;
Elsenbruch, S., Enck, P., The stress concept in gastroenterology: from Selye to today (2017) F1000Research, 6, p. 2149;
Elsenbruch, S., Langhorst, J., Popkirowa, K., Muller, T., Luedtke, R., Franken, U., Paul, A., Dobos, G.J., Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis (2005) Psychother. Psychosom., 74, pp. 277-287;
Elsenbruch, S., Lucas, A., Holtmann, G., Haag, S., Gerken, G., Riemenschneider, N., Langhorst, J., Schedlowski, M., Public speaking stress-induced neuroendocrine responses and circulating immune cell redistribution in irritable bowel syndrome (2006) Am. J. Gastroenterol., 101, pp. 2300-2307;
Elsenbruch, S., Roderigo, T., Enck, P., Benson, S., Can a brief relaxation exercise modulate placebo or nocebo effects in a visceral pain model? (2019) Front. Psychiatry, 10, p. 144;
Elsenbruch, S., Rosenberger, C., Bingel, U., Forsting, M., Schedlowski, M., Gizewski, E.R., Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli (2010) Gastroenterology, 139, pp. 1310-1319;
Elsenbruch, S., Rosenberger, C., Enck, P., Forsting, M., Schedlowski, M., Gizewski, E.R., Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: an fMRI study (2010) Gut, 59, pp. 489-495;
Elsenbruch, S., Wolf, O.T., Could stress contribute to pain-related fear in chronic pain? (2015) Front. Behav. Neurosci., 9, p. 340;
Enck, P., Aziz, Q., Barbara, G., Farmer, A.D., Fukudo, S., Mayer, E.A., Niesler, B., Spiller, R.C., Irritable bowel syndrome (2016) Nat. Rev. Dis. Primers, 2, p. 16014;
Enck, P., Azpiroz, F., Boeckxstaens, G., Elsenbruch, S., Feinle-Bisset, C., Holtmann, G., Lackner, J.M., Talley, N.J., Functional dyspepsia (2017) Nat. Rev. Dis. Primers, 3, p. 17081;
Engler, H., Brendt, P., Wischermann, J., Wegner, A., Rohling, R., Schoemberg, T., Meyer, U., Schedlowski, M., Selective increase of cerebrospinal fluid IL-6 during experimental systemic inflammation in humans: association with depressive symptoms (2017) Mol. Psychiatry, 22, pp. 1448-1454;
Engler, H., Doenlen, R., Engler, A., Riether, C., Prager, G., Niemi, M.B., Pacheco-Lopez, G., Schedlowski, M., Acute amygdaloid response to systemic inflammation (2011) Brain Behav. Immun., 25, pp. 1384-1392;
Engler, H., Elsenbruch, S., Rebernik, L., Kocke, J., Cramer, H., Schols, M., Langhorst, J., Stress burden and neuroendocrine regulation of cytokine production in patients with ulcerative colitis in remission (2018) Psychoneuroendocrinology, 98, pp. 101-107;
Ewais, T., Begun, J., Kenny, M., Chuang, K.H., Barclay, J., Hay, K., Kisely, S., Protocol for a pilot randomised controlled trial of mindfulness-based cognitive therapy in youth with inflammatory bowel disease and depression (2019) BMJ Open, 9;
Farhadi, A., Keshavarzian, A., Van de Kar, L.D., Jakate, S., Domm, A., Zhang, L., Shaikh, M., Fields, J.Z., Heightened responses to stressors in patients with inflammatory bowel disease (2005) Am. J. Gastroenterol., 100, pp. 1796-1804;
Farmer, A.D., Coen, S.J., Kano, M., Paine, P.A., Shwahdi, M., Jafari, J., Kishor, J., Aziz, Q., Psychophysiological responses to pain identify reproducible human clusters (2013) Pain, 154, pp. 2266-2276;
Fass, R., Naliboff, B.D., Fass, S.S., Peleg, N., Wendel, C., Malagon, I.B., Mayer, E.A., The effect of auditory stress on perception of intraesophageal acid in patients with gastroesophageal reflux disease (2008) Gastroenterology, 134. , 696-505;
Fava, G.A., Pavan, L., Large bowel disorders. I. Illness configuration and life events (1976) Psychother. Psychosom., 27, pp. 93-99;
Feldman, F., Cantor, D., Soll, S., Bachrach, W., Psychiatric study of a consecutive series of 34 patients with ulcerative colitis (1967) Br. Med. J., 3, pp. 14-17;
Ford, A.C., Forman, D., Bailey, A.G., Axon, A.T., Moayyedi, P., Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior (2008) Am. J. Gastroenterol., 103, pp. 1229-1239;
Ford, A.C., Lacy, B.E., Harris, L.A., Quigley, E.M., Moayyedi, P., Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis (2019) Am. J. Gastroenterol., 114, pp. 21-39;
Ford, M.J., Camilleri, M., Zinsmeister, A.R., Hanson, R.B., Psychosensory modulation of colonic sensation in the human transverse and sigmoid colon (1995) Gastroenterology, 109, pp. 1772-1780;
Fournier, A., Mondillon, L., Dantzer, C., Gauchez, A.S., Ducros, V., Mathieu, N., Faure, P., Pellissier, S., Emotional overactivity in patients with irritable bowel syndrome (2018) Neurogastroenterol. Motil., 30;
Franchimont, D., Louis, E., Dupont, P., Vrindts-Gevaert, Y., Dewe, W., Chrousos, G., Geenen, V., Belaiche, J., Decreased corticosensitivity in quiescent Crohn's disease: an ex vivo study using whole blood cell cultures (1999) Dig. Dis. Sci., 44, pp. 1208-1215;
Frokjaer, J.B., Bergmann, S., Brock, C., Madzak, A., Farmer, A.D., Ellrich, J., Drewes, A.M., Modulation of vagal tone enhances gastroduodenal motility and reduces somatic pain sensitivity (2016) Neurogastroenterol. Motil., 28, pp. 592-598;
Fujiwara, T., Kono, S., Katakura, K., Abe, K., Takahashi, A., Gunji, N., Yokokawa, A., Ohira, H., Evaluation of brain activity using near-infrared spectroscopy in inflammatory bowel disease patients (2018) Sci. Rep., 8, p. 402;
Fukudo, S., Stress and visceral pain: focusing on irritable bowel syndrome (2013) Pain, 154, pp. S63-70;
Goodman, W.K., Janson, J., Wolf, J.M., Meta-analytical assessment of the effects of protocol variations on cortisol responses to the Trier Social Stress Test (2017) Psychoneuroendocrinology, 80, pp. 26-35;
Gracie, D.J., Guthrie, E.A., Hamlin, P.J., Ford, A.C., Bi-directionality of brain-gut interactions in patients with inflammatory bowel disease (2018) Gastroenterology, 154, pp. 1635-1646;
Gracie, D.J., Hamlin, P.J., Ford, A.C., The influence of the brain-gut axis in inflammatory bowel disease and possible implications for treatment (2019) Lancet Gastroenterol. Hepatol., 4, pp. 632-642;
Graff, L.A., Walker, J.R., Clara, I., Lix, L., Miller, N., Rogala, L., Rawsthorne, P., Bernstein, C.N., Stress coping, distress, and health perceptions in inflammatory bowel disease and community controls (2009) Am. J. Gastroenterol., 104, pp. 2959-2969;
Gray, M.A., Chao, C.Y., Staudacher, H.M., Kolosky, N.A., Talley, N.J., Holtmann, G., Anti-TNF-α therapy in IBD alters brain activity reflecting visceral sensory function and cognitive-affective biases (2018) PLoS One, 13;
Greenwood-Van Meerveld, B., Prusator, D.K., Johnson, A.C., Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: pathophysiology, translational relevance, and challenges (2015) Am. J. Physiol. Gastrointest. Liver Physiol., 308, pp. G885-903;
Hashash, J.G., Binion, D.G., Exercise and inflammatory bowel disease: insights into etiopathogenesis and modification of clinical course (2017) Gastroenterol. Clin. North Am., 46, pp. 895-905;
Holtmann, G., Singer, M.V., Kriebel, R., Stacker, K.H., Goebell, H., Differential effects of acute mental stress on interdigestive secretion of gastric acid, pancreatic enzymes, and gastroduodenal motility (1989) Dig. Dis. Sci., 34, pp. 1701-1707;
Hong, J.Y., Labus, J.S., Jiang, Z., Ashe-Mcnalley, C., Dinov, I., Gupta, A., Shi, Y., Mayer, E.A., Regional neuroplastic brain changes in patients with chronic inflammatory and non-inflammatory visceral pain (2014) PLoS One, 9;
Huang, J.S., Terrones, L., Simmons, A.N., Kaye, W., Strigo, I., Pilot study of functional magnetic resonance imaging responses to somatic pain stimuli in youth with functional and inflammatory gastrointestinal disease (2016) J. Pediatr. Gastroenterol. Nutr., 63, pp. 500-507;
Hubbard, C.S., Labus, J.S., Bueller, J., Stains, J., Suyenobu, B., Dukes, G.E., Kelleher, D.L., Mayer, E.A., Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain (2011) J. Neurosci., 31, pp. 12491-12500;
Hughes, P.A., Zola, H., Penttila, I.A., Blackshaw, L.A., Andrews, J.M., Krumbiegel, D., Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms? (2013) Am. J. Gastroenterol., 108, pp. 1066-1074;
Icenhour, A., Labrenz, F., Ritter, C., Theysohn, N., Forsting, M., Bingel, U., Elsenbruch, S., Learning by experience? Visceral pain-related neural and behavioral responses in a classical conditioning paradigm (2017) Neurogastroenterol. Motil., 29;
Icenhour, A., Langhorst, J., Benson, S., Schlamann, M., Hampel, S., Engler, H., Forsting, M., Elsenbruch, S., Neural circuitry of abdominal pain-related fear learning and reinstatement in irritable bowel syndrome (2015) Neurogastroenterol. Motil., 27, pp. 114-127;
Icenhour, A., Tapper, S., Bednarska, O., Witt, S.T., Tisell, A., Lundberg, P., Elsenbruch, S., Walter, S., Elucidating the putative link between prefrontal neurotransmission, functional connectivity, and affective symptoms in irritable bowel syndrome (2019) Sci. Rep., , in press;
Irwin, C., Falsetti, S.A., Lydiard, R.B., Ballenger, J.C., Brock, C.D., Brener, W., Comorbidity of posttraumatic stress disorder and irritable bowel syndrome (1996) J. Clin. Psychiatry, 57, pp. 576-578;
Ishihara, S., Kawashima, K., Fukuba, N., Tada, Y., Kotani, S., Mishima, Y., Oshima, N., Kinoshita, Y., Irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission: association with residual colonic inflammation (2019) Digestion, 99, pp. 46-51;
Jacobs, J.P., Mayer, E.A., Psychobiotics: shaping the mind with gut bacteria (2019) Am. J. Gastroenterol., 114, pp. 1034-1035;
Jarcho, J.M., Feier, N.A., Bert, A., Labus, J.S., Lee, M., Stains, J., Ebrat, B., Mayer, E.A., Diminished neurokinin-1 receptor availibility in patients with two forms of chronic visceral pain (2013) Pain, 154, pp. 987-996;
Jarrett, M., Heitkemper, M., Cain, K.C., Tuftin, M., Walker, E.A., Bond, E.F., Levy, R.L., The relationship between psychological distress and gastrointestinal symptoms in women with irritable bowel syndrome (1998) Nurs. Res., 47, pp. 154-161;
Jones, M.P., Tack, J., Van Oudenhove, L., Walker, M.M., Holtmann, G., Koloski, N.A., Talley, N.J., Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population (2017) Clin. Gastroenterol. Hepatol., 15, pp. 1014-1020;
Karl, J.P., Margolis, L.M., Madslien, E.H., Murphy, N.E., Castellani, J.W., Gundersen, Y., Hoke, A.V., Pasiakos, S.M., Changes in intestinal microbiota composition and metabolism coincide with increased intestinal permeability in young adults under prolonged physiological stress (2017) Am. J. Physiol. Gastrointest. Liver Physiol., 312, pp. G559-G571;
Kato-Kataoka, A., Nishida, K., Takada, M., Kawai, M., Kikuchi-Hayakawa, H., Suda, K., Ishikawa, H., Rokutan, K., Fermented milk containing Lactobacillus casei strain shirota preserves the diversity of the gut microbiota and relieves abdominal dysfunction in healthy medical students exposed to academic stress (2016) Appl. Environ. Microbiol., 82, pp. 3649-3658;
Keefer, L., Behavioural medicine and gastrointestinal disorders: the promise of positive psychology (2018) Nat. Rev. Gastroenterol. Hepatol., 15, pp. 378-386;
Kelly, J.R., Allen, A.P., Temko, A., Hutch, W., Kennedy, P.J., Farid, N., Murphy, E., Dinan, T.G., Lost in translation? The potential psychobiotic Lactobacillus rhamnosus (JB-1) fails to modulate stress or cognitive performance in healthy male subjects (2017) Brain Behav. Immun., 61, pp. 50-59;
Kelly, J.R., Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Hyland, N.P., Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders (2015) Front. Cell. Neurosci., 9, p. 392;
Kennedy, P.J., Clarke, G., Quigley, E.M., Groeger, J.A., Dinan, T.G., Cryan, J.F., Gut memories: towards a cognitive neurobiology of irritable bowel syndrome (2012) Neurosci. Biobehav. Rev., 36, pp. 310-340;
Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Kynurenine pathway metabolism and the microbiota-gut-brain axis (2017) Neuropharmacology, 112, pp. 399-412;
Kennedy, P.J., Cryan, J.F., Quigley, E.M., Dinan, T.G., Clarke, G., A sustained hypothalamic-pituitary-adrenal axis response to acute psychosocial stress in irritable bowel syndrome (2014) Psychol. Med. (Paris), 44, pp. 3123-3134;
Kirschbaum, C., Pirke, K.M., Hellhammer, D.H., The’ Trier Social Stress Test’--a tool for investigating psychobiological stress responses in a laboratory setting (1993) Neuropsychobiology, 28, pp. 76-81;
Knowles, S.R., Graff, L.A., Wilding, H., Hewitt, C., Keefer, L., Mikocka-Walus, A., Quality of life in inflammatory bowel disease: a systematic review and meta-analyses - Part I. Inflam (2018) J. Inflamm. Bowel Dis. Disord., 24, pp. 742-751;
Knowles, S.R., Keefer, L., Wilding, H., Hewitt, C., Graff, L.A., Mikocka-Walus, A., Quality of life in inflammatory bowel disease: a systematic review and meta-analyses - Part II. Inflam (2018) J. Inflamm. Bowel Dis. Disord., 24, pp. 966-976;
Koenen, L.R., Icenhour, A., Forkmann, K., Theysohn, N., Forsting, M., Bingel, U., Elsenbruch, S., From anticipation to the experience of pain: the importance of visceral versus somatic pain modality in neural and behavioral responses to pain-predictive cues (2018) Psychosom. Med., 80, pp. 826-835;
Koloski, N.A., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., Talley, N.J., The brain--gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study (2012) Gut, 61, pp. 1284-1290;
Koloski, N.A., Jones, M., Talley, N.J., Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study (2016) Aliment. Pharmacol. Ther., 44, pp. 592-600;
Kuroki, T., Ohta, A., Sherriff-Tadano, R., Matsuura, E., Takashima, T., Iwakiri, R., Fujimoto, K., Imbalance in the stress-adaptation system in patients with inflammatory bowel disease (2011) Biol. Res. Nurs., 13, pp. 391-398;
Labrenz, F., Ferri, F., Wrede, K., Forsting, M., Schedlowski, M., Engler, H., Elsenbruch, S., Costantini, M., Altered temporal variance and functional connectivity of BOLD signal is associated with state anxiety during acute systemic inflammation (2019) NeuroImage, 184, pp. 916-924;
Labrenz, F., Wrede, K., Forsting, M., Engler, H., Schedlowski, M., Elsenbruch, S., Benson, S., Alterations in functional connectivity of resting state networks during experimental endotoxemia - an exploratory study in healthy men (2016) Brain Behav. Immun., 54, pp. 17-26;
Labus, J.S., Hubbard, C.S., Bueller, J., Ebrat, B., Tillisch, K., Chen, M., Stains, J., Mayer, E.A., Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome (2013) Gastroenterology, 145, pp. 1253-1261;
Labus, J.S., Osadchiy, V., Hsiao, E.Y., Tap, J., Derrien, M., Gupta, A., Tillisch, K., Mayer, E.A., Evidence for an association of gut microbial Clostridia with brain functional connectivity and gastrointestinal sensorimotor function in patients with irritable bowel syndrome, based on tripartite network analysis (2019) Microbiome, 7, p. 45;
Lackner, J.M., Gudleski, G.D., Thakur, E.R., Stewart, T.J., Iacobucci, G.J., Spiegel, B.M., The impact of physical complaints, social environment, and psychological functioning on IBS patients’ health perceptions: looking beyond GI symptom severity (2014) Am. J. Gastroenterol., 109, pp. 224-233;
Langhorst, J., Anthonisen, I.B., Steder-Neukamm, U., Ludtke, R., Spahn, G., Michalsen, A., Dobos, G.J., Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey (2005) J. Inflamm. Bowel Dis. Disord., 11, pp. 287-295;
Langhorst, J., Cobelens, P.M., Kavelaars, A., Heijnen, C.J., Benson, S., Rifaie, N., Dobos, G.J., Elsenbruch, S., Stress-related peripheral neuroendocrine-immune interactions in women with ulcerative colitis (2007) Psychoneuroendocrinology, 32, pp. 1086-1096;
Langhorst, J., Hofstetter, A., Wolfe, F., Hauser, W., Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study (2013) J. Inflamm. Bowel Dis. Disord., 19, pp. 2380-2386;
Langhorst, J., Mueller, T., Luedtke, R., Franken, U., Paul, A., Michalsen, A., Schedlowski, M., Elsenbruch, S., Effects of a comprehensive lifestyle modification program on quality-of-life in patients with ulcerative colitis: a twelve-month follow-up (2007) Scand. J. Gastroenterol., 42, pp. 734-745;
Langhorst, J., Wulfert, H., Lauche, R., Klose, P., Cramer, H., Dobos, G.J., Korzenik, J., Systematic review of complementary and alternative medicine treatments in inflammatory bowel diseases (2015) J. Crohns Colitis, 9, pp. 86-106;
Lerebours, E., Gower-Rousseau, C., Merle, V., Brazier, F., Debeugny, S., Marti, R., Salomez, J.L., Benichou, J., Stressful life events as a risk factor for inflammatory bowel disease onset: a population-based case-control study (2007) Am. J. Gastroenterol., 102, pp. 122-131;
Levenstein, S., Prantera, C., Varvo, V., Scribano, M.L., Andreoli, A., Luzi, C., Arca, M., Marcheggiano, A., Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission (2000) Am. J. Gastroenterol., 95, pp. 1213-1220;
Levenstein, S., Prantera, C., Varvo, V., Scribano, M.L., Berto, E., Andreoli, A., Luzi, C., Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study (1994) Am. J. Gastroenterol., 89, pp. 1219-1225;
Li, J., Norgard, B., Precht, D.H., Olsen, J., Psychological stress and inflammatory bowel disease: a follow-up study in parents who lost a child in Denmark (2004) Am. J. Gastroenterol., 99, pp. 1129-1133;
Ljotsson, B., Hesser, H., Andersson, E., Lackner, J.M., El Alaoui, S., Falk, L., Aspvall, K., Hedman, E., Provoking symptoms to relieve symptoms: a randomized controlled dismantling study of exposure therapy in irritable bowel syndrome (2014) Behav. Res. Ther., 55, pp. 27-39;
Locke, G.R., 3rd, Weaver, A.L., Melton, L.J., 3rd, Talley, N.J., Psychosocial factors are linked to functional gastrointestinal disorders: a population based nested case-control study (2004) Am. J. Gastroenterol., 99, pp. 350-357;
Lowe, B., Lohse, A., Andresen, V., Vettorazzi, E., Rose, M., Broicher, W., The development of irritable bowel syndrome: a prospective community-based cohort study (2016) Am. J. Gastroenterol., 111, pp. 1320-1329;
Lucas, A., Cobelens, P.M., Kavelaars, A., Heijnen, C.J., Holtmann, G., Haag, S., Gerken, G., Elsenbruch, S., Disturbed in vitro adrenergic modulation of cytokine production in inflammatory bowel diseases in remission (2007) J. Neuroimmunol., 182, pp. 195-203;
Lv, K., Fan, Y.H., Xu, L., Xu, M.S., Brain changes detected by functional magnetic resonance imaging and spectroscopy in patients with Crohn's disease (2017) World J. Gastroenterol., 23, pp. 3607-3614;
Martin, C.R., Osadchiy, V., Kalani, A., Mayer, E.A., The brain-gut-microbiome axis (2018) Cell. Mol. Gastroenterol. Hepatol., 6, pp. 133-148;
Mawdsley, J.E., Rampton, D.S., Psychological stress in IBD: new insights into pathogenic and therapeutic implications (2005) Gut, 54, pp. 1481-1491;
Mawdsley, J.E., Rampton, D.S., The role of psychological stress in inflammatory bowel disease (2006) Neuroimmunomodulation, 13, pp. 327-336;
Mayer, E.A., Labus, J., Aziz, Q., Tracey, I., Kilpatrick, L.A., Elsenbruch, S., Schweinhardt, P., Borsook, D., The role of brain imaging in disorders of brain gut interactions - a Rome working team report (2019) Gut, , in press;
Melinder, C., Hiyoshi, A., Fall, K., Halfvarson, J., Montgomery, S., Stress resilience and the risk of inflammatory bowel disease: a cohort study of men living in Sweden (2017) BMJ Open, 7;
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Tillinger, W., Moser, G., Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study (2004) Psychosom. Med., 66, pp. 79-84;
Mizrahi, M.C., Reicher-Atir, R., Levy, S., Haramati, S., Wengrower, D., Israeli, E., Goldin, E., Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease (2012) Psychol. Health, 27, pp. 1463-1479;
Moloney, R.D., Johnson, A.C., O'Mahony, S.M., Dinan, T.G., Greenwood-Van Meerveld, B., Cryan, J.F., Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome (2016) CNS Neurosci. Ther., 22, pp. 102-117;
Moloney, R.D., O'Mahony, S.M., Dinan, T.G., Cryan, J.F., Stress-induced visceral pain: toward animal models of irritable-bowel syndrome and associated comorbidities (2015) Front. Psychiatry, 6, p. 15;
Murray, C.D., Flynn, J., Ratcliffe, L., Jacyna, M.R., Kamm, M.A., Emmanuel, A.V., Effect of acute physical and psychological stress on gut autonomic innervation in irritable bowel syndrome (2004) Gastroenterology, 127, pp. 1695-1703;
Nair, V.A., Beniwal-Patel, P., Mbah, I., Young, B.M., Prabhakaran, V., Saha, S., Structural imaging changes and behavioral correlates in patients with Crohn's disease in remission (2016) Front. Hum. Neurosci., 10, p. 460;
Ng, Q.X., Soh, A.Y.S., Loke, W., Lim, D.Y., Yeo, W.S., The role of inflammation in irritable bowel syndrome (IBS) (2018) J. Inflamm. Res., 11, pp. 345-349;
Ng, S.C., Shi, H.Y., Hamidi, N., Underwood, F.E., Tang, W., Benchimol, E.I., Panaccione, R., Kaplan, G.G., Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies (2018) Lancet, 390, pp. 2769-2778;
Osadchiy, V., Martin, C.R., Mayer, E.A., The gut-brain axis and the microbiome: mechanisms and clinical implications (2019) Clin. Gastroenterol. Hepatol., 17, pp. 322-332;
Paar, G.H., Bezzenberger, U., Lorenz-Meyer, H., The correlation of psychosocial stress and disease activity in patients with Crohn disease and ulcerative colitis (1988) Z. Gastroenterol., 26, pp. 648-657;
Park, S.H., Videlock, E.J., Shih, W., Presson, A.P., Mayer, E.A., Chang, L., Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity (2016) Neurogastroenterol. Motil., 28, pp. 1252-1260;
Pellissier, S., Dantzer, C., Canini, F., Mathieu, N., Bonaz, B., Psychological adjustment and autonomic disturbances in inflammatory bowel diseases and irritable bowel syndrome (2010) Psychoneuroendocrinology, 35, pp. 653-662;
Pellissier, S., Dantzer, C., Mondillon, L., Trocme, C., Gauchez, A.S., Ducros, V., Mathieu, N., Bonaz, B., Relationship between vagal tone, cortisol, TNF-α, epinephrine and negative affects in Crohn's disease and irritable bowel syndrome (2014) PLoS One, 9;
Phillips, M.L., Gregory, L.J., Cullen, S., Coen, S., Ng, V., Andrew, C., Giampietro, V., Aziz, Q., The effect of negative emotional context on neural and behavioral responses to oesophageal stimulation (2003) Brain, 126, pp. 669-684;
Pittayanon, R., Lau, J.T., Yuan, Y., Leontiadis, G.I., Tse, F., Surette, M., Moayyedi, P., Gut microbiota in patients with irritable bowel syndrome - a systematic review (2019) Gastroenterology, 157, pp. 97-108;
Posserud, I., Agerforz, P., Ekman, R., Bjornsson, E.S., Abrahamsson, H., Simren, M., Altered visceral perceptual and neuroendocrine response in patients with irritable bowel syndrome during mental stress (2004) Gut, 53, pp. 1102-1108;
Putignani, L., Del Chierico, F., Vernocchi, P., Cicala, M., Cucchiara, S., Dallapiccola, B., Gut microbiota dysbiosis as risk and premorbid factors of IBD and IBS along the childhood-adulthood transition (2016) J. Inflamm. Bowel Dis. Disord., 22, pp. 487-504;
Regueiro, M., Greer, J.B., Szigethy, E., Etiology and treatment of pain and psychosocial issues in patients with inflammatory bowel diseases (2017) Gastroenterology, 152 (430-439), p. e434;
Roderigo, T., Benson, S., Schols, M., Hetkamp, M., Schedlowski, M., Enck, P., Elsenbruch, S., Effects of acute psychological stress on placebo and nocebo responses in a clinically relevant model of visceroception (2017) Pain, 158, pp. 1489-1498;
Rohleder, N., Acute and chronic stress induced changes in sensitivity of peripheral inflammatory pathways to the signals of multiple stress systems -- 2011 Curt Richter Award Winner (2012) Psychoneuroendocrinology, 37, pp. 307-316;
Rosenberger, C., Elsenbruch, S., Scholle, A., de Greiff, A., Schedlowski, M., Forsting, M., Gizewski, E.R., Effects of psychological stress on the cerebral processing of visceral stimuli in healthy women (2009) Neurogastroenterol. Motil., 21, pp. 740-e745;
Rubio, A., Pellissier, S., Van Oudenhove, L., Ly, H.G., Dupont, P., Tack, J., Dantzer, C., Bonaz, B., Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study (2016) Neurogastroenterol. Motil., 28, pp. 1419-1432;
Santos, J., Saperas, E., Nogueiras, C., Mourelle, M., Antolin, M., Cadahia, A., Malagelada, J.R., Release of mast cell mediators into the jejunum by cold pain stress in humans (1998) Gastroenterology, 114, pp. 640-648;
Schemann, M., Frieling, T., Enck, P., To learn, to remember, to forget-How smart is the gut? (2019) Acta Physiol. Oxf. (Oxf);
Schumann, D., Anheyer, D., Lauche, R., Dobos, G., Langhorst, J., Cramer, H., Effect of yoga in the therapy of irritable bowel syndrome: a systematic review (2016) Clin. Gastroenterol. Hepatol., 14, pp. 1720-1731;
Schumann, D., Langhorst, J., Dobos, G., Cramer, H., Randomised clinical trial: yoga vs a low-FODMAP diet in patients with irritable bowel syndrome (2018) Aliment. Pharmacol. Ther., 47, pp. 203-211;
Sexton, K.A., Walker, J.R., Graff, L.A., Bernstein, M.T., Beatie, B., Miller, N., Sargent, M., Targownik, L.E., Evidence of bidirectional associations between perceived stress and symptom activity: a prospective longitudinal investigation in inflammatory bowel disease (2017) J. Inflamm. Bowel Dis. Disord., 23, pp. 473-483;
Sharkey, K.A., Beck, P.L., McKay, D.M., Neuroimmunophysiology of the gut: advances and emerging concepts focusing on the epithelium (2018) Nat. Rev. Gastroenterol. Hepatol., 15, pp. 765-784;
Shaw, L., Ehrlich, A., Relaxation training as a treatment for chronic pain caused by ulcerative colitis (1987) Pain, 29, pp. 287-293;
Sibelli, A., Chalder, T., Everitt, H., Workman, P., Windgassen, S., Moss-Morris, R., A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset (2016) Psychol. Med. (Paris), 46, pp. 3065-3080;
Singh, S., Graff, L.A., Bernstein, C.N., Do NSAIDs, antibiotics, infections, or stress trigger flares in IBD? (2009) Am. J. Gastroenterol., 104, pp. 1298-1313. , quiz 1314;
Spiller, R., Garsed, K., Postinfectious irritable bowel syndrome (2009) Gastroenterology, 136, pp. 1979-1988;
Spiller, R., Major, G., IBS and IBD - separate entities or on a spectrum? (2016) Nat. Rev. Gastroenterol. Hepatol., 13, pp. 613-621;
Stanghellini, V., Chan, F.K., Hasler, W.L., Malagelada, J.R., Suzuki, H., Tack, J., Talley, N.J., Gastroduodenal disorders (2016) Gastroenterology, 150, pp. 1380-1392;
Sternberg, E.M., Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens (2006) Nat. Rev. Immunol., 6, pp. 318-328;
Straub, R.H., Herfarth, H., Falk, W., Andus, T., Scholmerich, J., Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease? (2002) J. Neuroimmunol., 126, pp. 116-125;
Tache, Y., Bonaz, B., Corticotropin-releasing factor receptors and stress-related alterations of gut motor function (2007) J. Clin. Invest., 117, pp. 33-40;
Taft, T.H., Keefer, L., A systematic review of disease-related stigmatization in patients living with inflammatory bowel disease (2016) Clin. Exp. Gastroenterol., 9, pp. 49-58;
Takada, M., Nishida, K., Gondo, Y., Kikuchi-Hayakawa, H., Ishikawara, H., Suda, K., Kawai, M., Rokutan, K., Beneficial effects of Lactobacillus casei strain Shirota on academic stress-induced sleep disturbance in healthy adults: a double-blin, randomised, placebo-controlled trial (2017) Benef. Microbes, 8, pp. 153-162;
Takada, M., Nishida, K., Kataoka-Kato, A., Gondo, Y., Ishikawa, H., Suda, K., Kawai, M., Rokutan, K., Probiotic Lactobacillus casei strain Shirota relieves stress-associated symptoms by modulating the gut-brain interaction in human and animal models (2016) Neurogastroenterol. Motil., 28, pp. 1027-1036;
Talley, N.J., Functional gastrointestinal disorders as a public health problem (2008) Neurogastroenterol. Motil., 20, pp. 121-129;
Tanaka, Y., Kanazawa, M., Fukudo, S., Drossman, D.A., Biopsychosocial model of irritable bowel syndrome (2011) J. Neurogastroenterol. Motil., 17, pp. 131-139;
Targownik, L.E., Sexton, K.A., Bernstein, M.T., Beatie, B., Sargent, M., Walker, J.R., Graff, L.A., The relationship among perceived stress, symptoms, and inflammation in persons with inflammatory bowel disease (2015) Am. J. Gastroenterol., 110, pp. 1001-1012;
Thomann, A.K., Griebe, M., Thomann, P.A., Hirjak, D., Ebert, M.P., Szabo, K., Reindl, W., Wolf, R.C., Intrinsic neural network dysfunction in quiescent Crohn's Disease (2017) Sci. Rep., 7, p. 11579;
Thomann, A.K., Reindl, W., Wustenberg, T., Kmuche, D., Ebert, M.P., Szabo, K., Wolf, R.C., Thomann, P.A., Aberrant brain structural large-scale connectome in Crohn's disease (2019) Neurogastroenterol. Motil., 31;
Tillisch, K., Mayer, E.A., Gupta, A., Gill, Z., Brazeilles, R., Le Neve, B., van Hylckama Vlieg, J.E.T., Labus, J.S., Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women (2017) Psychosom. Med., 79, pp. 905-913;
Ulloa, L., The vagus nerve and the nicotinic anti-inflammatory pathway (2005) Nat. Rev. Drug Discov., 4, pp. 673-684;
Van Oudenhove, L., Crowell, M.D., Drossman, D.A., Halpert, A.D., Keefer, L., Lackner, J.M., Murphy, T.B., Levy, R.L., Biopsychosocial aspects of functional gastrointestinal disorders (2016) Gastroenterology, 150, pp. 1355-1367;
Van Oudenhove, L., Vandenberghe, J., Dupont, P., Geeraerts, B., Vos, R., Dirix, S., Bormans, G., Tack, J., Abnormal regional brain activity during rest and (anticipated) gastric distension in functional dyspepsia and the role of anxiety: a H(2)(15)O-PET study (2010) Am. J. Gastroenterol., 105, pp. 913-924;
Vanner, S., Greenwood-Van Meerveld, B., Mawe, G., Shea-Donohue, T., Verdu, E.F., Wood, J., Grundy, D., Fundamentals of neurogastroenterology: basic science (2016) Gastroenterology, 150, pp. 1280-1291;
Vanuytsel, T., van Wanrooy, S., Vanheel, H., Vanormelingen, C., Verschueren, S., Houben, E., Salim Rasoel, S., Tack, J., Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism (2014) Gut, 63, pp. 1293-1299;
Wang, H., Braun, C., Enck, P., Effects of Rifaximin on central responses to social Stress-a pilot experiment (2018) Neurotherapeutics, 15, pp. 807-818;
Wang, H., Braun, C., Murphy, E.F., Enck, P., Bifidobacterium longum 1714™ strain modulates brain activity of healthy volunteers during social stress (2019) Am. J. Gastroenterol., 114, pp. 1152-1162;
Wegner, A., Elsenbruch, S., Rebernik, L., Roderigo, T., Engelbrecht, E., Jager, M., Engler, H., Benson, S., Inflammation-induced pain sensitization in men and women: does sex matter in experimental endotoxemia? (2015) Pain, 156, pp. 1954-1964;
Weltens, N., Iven, J., Van Oudenhove, L., Kano, M., The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation (2018) Ann. N.Y. Acad. Sci., 1428, pp. 129-150;
Witt, S.T., Bednarska, O., Keita, A.V., Icenhour, A., Jones, M.P., Elsenbruch, S., Soderholm, J.D., Walter, S., Interactions between gut permeability and brain structure and function in health and irritable bowel syndrome (2019) Neuroimage Clin., 21;
Yamasaki, T., Tomita, T., Takimoto, M., Kondo, T., Tozawa, K., Ohda, Y., Oshima, T., Miwa, H., Intravenous corticotropin-releasing hormone administration increases esophageal electrical sensitivity in healthy individuals (2017) J. Neurogastroenterol. Motil., 23, pp. 526-532;
Zijdenbos, I.L., de Wit, N.J., van der Heijden, G.J., Rubin, G., Quartero, A.O., Psychological treatments for the management of irritable bowel syndrome (2009) Cochrane Database Syst. Rev.
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074596690&doi=10.1016%2fj.psyneuen.2019.104501&partnerID=40&md5=a22a980b0c8e033a036830f360e7b895
ER  -

TY  - JOUR
TI  - Hypothesis: Mechanism of irritable bowel syndrome in inflammatory bowel disease
T2  - Medical Hypotheses
J2  - Med. Hypotheses
VL  - 132
PY  - 2019
DO  - 10.1016/j.mehy.2019.109324
SN  - 03069877 (ISSN)
AU  - Uno, Y.
AD  - Office Uno Column, 419-2, Yota, Onoe-Cho, Kakogawa, Hyogo, Japan
AB  - Functional bowel symptoms can be occurred during remission from inflammatory bowel disease. In this case, a low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) diet is effective for the amelioration or prevention of symptoms. However, the reason is not fully explained. This report proposes a hypothesis regarding the entire process in which inflammatory bowel disease with IBS-like symptoms (IBD-IBS) causes symptoms. A detailed process was assumed, starting from high pressure in the lumen and finally to abdominal symptoms. In this process, relationships were linked based on interactions such as ischemia, compliance, pain threshold, visceral hypersensitivity, mast cells, and permeability reported in IBD-IBS. In the process mapping, to understand the relationship between the amount of gas increased by FODMAP and ischemia, the hydrodynamic hypothesis and Ritchie's hypothesis were adapted. Ischemia in dilated intestines due to an increase in gas volume can induce excessive spasms via the mast cells and show the whole process of lowering the pain threshold. From the standpoint of the mechanism of IBD-IBS, the origin trigger may be FODMAP. Therefore, a low-FODMAP diet is recommended to relieve and prevent IBD-IBS symptoms. © 2019
KW  - FODMAP
KW  - Inflammatory bowel disease
KW  - Irritable bowel syndrome
KW  - Ischemia
KW  - Mast cell
KW  - hydrogen sulfide
KW  - short chain fatty acid
KW  - vanilloid receptor 1
KW  - abdominal discomfort
KW  - abdominal distension
KW  - abdominal pain
KW  - Article
KW  - bacterial overgrowth
KW  - constipation
KW  - Crohn disease
KW  - diarrhea
KW  - dysbiosis
KW  - feces incontinence
KW  - human
KW  - inflammatory bowel disease
KW  - intestine blood flow
KW  - intestine mucosa permeability
KW  - intestine pressure
KW  - intestine transit time
KW  - irritable colon
KW  - low FODMAP diet
KW  - malabsorption
KW  - mast cell
KW  - nonhuman
KW  - pain threshold
KW  - toxic megacolon
KW  - ulcerative colitis
PB  - Churchill Livingstone
N1  - Export Date: 18 November 2019
M3  - Article
DB  - Scopus
C7  - 109324
N1  - CODEN: MEHYD
C2  - 31421429
LA  - English
N1  - Chemicals/CAS: hydrogen sulfide, 15035-72-0, 7783-06-4; vanilloid receptor 1, 363242-41-5
N1  - References: Isgar, B., Harman, M., Kaye, M.D., Whorwell, P.J., Symptoms of irritable bowel syndrome in ulcerative colitis in remission (1983) Gut, 24, pp. 190-192;
Simrén, M., Axelsson, J., Gillberg, R., Abrahamsson, H., Svedlund, J., Björnsson, E.S., Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors (2002) Am J Gastroenterol, 97, pp. 389-396;
Minderhoud, I.M., Oldenburg, B., Wismeijer, J.A., van Berge Henegouwen, G.P., Smout, A.J., IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior (2004) Dig Dis Sci, 49, pp. 469-474;
Barratt, H.S., Kalantzis, C., Polymeros, D., Forbes, A., Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status (2005) Aliment Pharmacol Ther, 21, pp. 141-147;
Halpin, S.J., Ford, A.C., Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis (2012) Am J Gastroenterol, 107, pp. 1474-1482;
Bercik, P., Verdu, E.F., Collins, S.M., Is irritable bowel syndrome a low-grade inflammatory bowel disease? (2005) Gastroenterol Clin North Am, 34, pp. 235-245;
Sinagra, E., Morreale, G.C., Mohammadian, G., New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond (2017) World J Gastroenterol, 23, pp. 6593-6627;
El-Salhy, M., Gundersen, D., Gilja, O.H., Hatlebakk, J.G., Hausken, T., Is irritable bowel syndrome an organic disorder? (2014) World J Gastroenterol, 20, pp. 384-400;
Keohane, J., O'Mahony, C., O'Mahony, L., O'Mahony, S., Quigley, E.M., Shanahan, F., Irritable bowel Syndrome-Type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? (2010) Am J Gastroenterol, 105, pp. 1789-1794;
Jelsness-Jørgensen, L.P., Bernklev, T., Moum, B., Fatigue and disease-related worries among inflammatory bowel disease patients in remission; is it a reflection of coexisting IBS-like symptoms? A short report (2012) J Psychosom Res, 73, pp. 469-472;
Jonefjäll, B., Öhman, L., Simrén, M., Strid, H., IBS-like symptoms in patients with ulcerative colitis in deep remission are associated with increased levels of serum cytokines and poor psychological well-being (2016) Inflamm Bowel Dis, 22, pp. 2630-2640;
Diederen, K., Hoekman, D.R., Hummel, T.Z., The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity (2016) Aliment Pharmacol Ther, 44, pp. 181-188;
Hoekman, D.R., Zeevenhooven, J., D'Haens, G.R., Benninga, M.A., The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission (2017) Eur J Gastroenterol Hepatol, 29, pp. 1086-1090;
Henriksen, M., Høivik, M.L., Jelsness-Jørgensen, L.P., Moum, B., Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as in inflammation: results from a population-based study (2018) J Crohns Colitis, 12, pp. 389-393;
Ishihara, S., Kawashima, K., Fukuba, N., Irritable bowel syndrome-like symptoms in ulcerative colitis patients in clinical remission: association with residual colonic inflammation (2019) Digestion, 99, pp. 46-51;
Berrill, J.W., Green, J.T., Hood, K., Campbell, A.K., Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity (2013) Aliment Pharmacol Ther, 38, pp. 44-51;
Mavroudis, G., Simren, M., Jonefjäll, B., Öhman, L., Strid, H., Symptoms compatible with functional bowel disorders are common in patients with quiescent ulcerative colitis and influence the quality of life but not the course of the disease (2019) Therap Adv Gastroenterol, 12. , 1756284819827689;
Jonefjäll, B., Simrén, M., Öhman, L., Lasson, A., Svedlund, J., Strid, H., The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission (2015) J Crohns Colitis, 9, pp. 776-783;
Tomita, T., Kato, Y., Takimoto, M., Prevalence of irritable bowel syndrome-like symptoms in Japanese patients with inactive inflammatory bowel disease (2016) J Neurogastroenterol Motil, 22, pp. 661-669;
Abdalla, M.I., Sandler, R.S., Kappelman, M.D., Prevalence and impact of inflammatory bowel disease-irritable bowel syndrome on patient-reported outcomes in CCFA partners (2017) Inflamm Bowel Dis, 23, pp. 325-331;
Gracie, D.J., Williams, C.J., Sood, R., Negative effects on psychological health and quality of life of genuine irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease (2017) Clin Gastroenterol Hepatol, 15, pp. 376-385;
Gracie, D.J., Hamlin, J.P., Ford, A.C., Longitudinal impact of IBS-type symptoms on disease activity, healthcare utilization, psychological health, and quality of life in inflammatory bowel disease (2018) Am J Gastroenterol, 113, pp. 702-712;
Zargar, A., Gooraji, S.A., Keshavarzi, B., Haji Aghamoha, A.A., Effect of irritable bowel syndrome on sleep quality and quality of life of inflammatory bowel disease in clinical remission (2019) Int J Prev Med, 10, p. 10;
Perera, L.P., Radigan, M., Guilday, C., Presence of irritable bowel syndrome symptoms in quiescent inflammatory bowel disease is associated with high rate of anxiety and depression (2019) Dig Dis Sci, 64, pp. 1923-1928;
Holt, D.Q., Strauss, B.J., Moore, G.T., Patients with inflammatory bowel disease and their treating clinicians have different views regarding diet (2017) J Hum Nutr Diet, 30, pp. 66-72;
Colombel, J.F., Shin, A., Gibson, P.R., AGA clinical practice update on functional gastrointestinal symptoms in patients with inflammatory bowel disease: expert review (2019) Clin Gastroenterol Hepatol, 17, pp. 380-390;
Prince, A.C., Myers, C.E., Joyce, T., Irving, P., Lomer, M., Whelan, K., Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease (2016) Inflamm Bowel Dis, 22, pp. 1129-1136;
Pedersen, N., Ankersen, D.V., Felding, M., Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel disease (2017) World J Gastroenterol, 23, pp. 3356-3366;
Elhusseiny, M.H., Amine, A.K., Salem, O.E., Tayel, D.I., Elsayed, E.A., Low FODMAP diet in Egyptian patients with Crohn's disease in remission phase with functional gastrointestinal symptoms (2018) JGH Open, 2, pp. 15-20;
Cox, S.R., Prince, A.C., Myers, C.E., Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial (2017) J Crohns Colitis, 11, pp. 1420-1429;
Gibson, P.R., Shepherd, S.J., Personal view: food for thought-western lifestyle and susceptibility to Crohn's disease. The FODMAP hypothesis (2005) Aliment Pharmacol Ther, 21, pp. 1399-1409;
Major, G., Pritchard, S., Murray, K., Colon hypersensitivity to distension, rather than excessive gas production, produces carbohydrate-related symptoms in individuals with irritable bowel syndrome (2017) Gastroenterology, 152, pp. 124-133;
Uno, Y., van Velkinburgh, J.C., Logical hypothesis: low FODMAP diet to prevent diverticulitis (2016) World J Gastrointest Pharmacol Ther, 7, pp. 503-512;
Uno, Y., Colonic transit time and pressure based on Bernoulli's principle (2018) Clin Exp Gastroenterol, 11, pp. 153-163;
Uno, Y., Enigma of intestinal gas in irritable bowel syndrome (2017) Am J Gastroenterol, 112, pp. 1166-1167;
Uno, Y., Management of colon stents based on Bernoulli's principle (2017) Indian J Gastroenterol, 36, pp. 69-74;
Uno, Y., Low-FODMAP diet for exercise-induced gastrointestinal syndrome (2017) Aliment Pharmacol Ther, 46, pp. 1021-1022;
Uno, Y., Irritable bowel syndrome-how a low-FODMAP diet or yoga might help (2018) Aliment Pharmacol Ther, 47, pp. 444-445;
Uno, Y., Radiation-induced enteropathy- how a low-FODMAP diet might help (2018) Scand J Gastroenterol, 53, pp. 377-378;
Uno, Y., Nakamura, M., Japanese low FODMAP diet manual (2019), Cambridge Scholars Publishing UK; Uno, Y., Introducer method of percutaneous endoscopic cecostomy and antegrade continence enema by use of the Chait Trapdoor cecostomy catheter in patients with adult neurogenic bowel (2006) Gastrointest Endosc, 63, pp. 666-673;
Ritchie, J.A., The relationship of ileal outflow to colonic propulsion (1969) Dis Colon Rectum, 12, pp. 129-136;
Matts, S.G.F., Gaskell, K.H., Retrograde colonic spread of enemata in ulcerative colitis (1961) Br Med J, 2 (5252), pp. 614-616;
Zagoria, R.J., Gelfand, D.W., Ott, D.J., Retrograde examination of the small bowel in patients with an ileostomy (1986) Gastrointest Radiol, 11, pp. 97-101;
Rokkas, T., Psaras, C., Niotis, E., Stefanopoulos, T., Patedakis, G., Endoscopic retrograde ileography (1992) Gastrointest Endosc, 38, pp. 375-376;
Clemens, C.H.M., Samsom, M., Van Berge Henegouwen, G.P., Smout, A.J.P.M., Abnormalities of left colonic motility in ambulant nonconstipated patients with irritable bowel syndrome (2003) Dig Dis Sci, 48, pp. 74-82;
Bharucha, A.E., High amplitude propagated contractions (2012) Neurogastroenterol Motil, 24, pp. 977-982;
Murray, K., Hoad, C.L., Mudie, D.M., Magnetic resonance imaging quantification of pasted state colonic liquid pockets in Healthy Humans (2017) Mocoxl Pharm, 14, pp. 2629-3238;
Lawal, A., Barboi, A., Krasnow, A., Hellman, R., Jaradeh, S., Massey, B.T., Rapid gastric emptying is more common than gastroparesis in patients with autonomic dysfunction (2007) Am J Gastroenterol, 102, pp. 618-623;
Read, N.W., Al-Janabi, M.N., Holgate, A.M., Barber, D.C., Edwards, C.A., Simultaneous measurement of gastric emptying, small bowel residence and colonic filling of a solid meal by the use of the gamma camera (1986) Gut, 27, pp. 300-308;
Louis, E., Collard, A., Oger, A.F., Degroote, E., Aboul Nasr El Yafi, F.A., Belaiche, J., Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease (2001) Gut, 49, pp. 777-782;
Prassopoulos, P., Papanikolaou, N., Grammatikakis, J., Rousomoustakaki, M., Maris, T., Gourtsoyiannis, N., MR enteroclysis imaging of Crohn disease (2001) Radiographics, 21, pp. S161-S172;
Calabrese, E., La Seta, F., Buccellato, A., Crohn's disease: a comparative prospective study of transabdominal ultrasonography, small intestine contrast ultrasonography, and small bowel enema (2005) Inflamm Bowel Dis, 11, pp. 139-145;
Sailer, J., Peloschek, P., Schober, E., Diagnostic value of CT enteroclysis compared with conventional enteroclysis in patients with Crohn's disease (2005) Am J Roentgenol, 185, pp. 1575-1581;
Bossuyt, P., Debeuckelaere, C., Ferrante, M., Risk stratification for surgery in stricturing ileal Crohn's disease: the BACARDI risk model (2018) J Crohns Colitis, 12, pp. 32-38;
De Dombal, F.T., Watts, J.M., Watkinson, G., Goligher, J.C., Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum (1966) Br Med J, 1 (5501), pp. 1442-1447;
Edwards, F.C., Truelove, S.C., Course and prognosis of ulcerative colitis (1964) Gut, 5, pp. 1-22;
Antonopoulos, P., Almyroudi, M., Kolonia, V., Kouris, S., Troumpoukis, N., Economou, N., Toxic megacolon and acute ischemia of the colon due to sigmoid stenosis related to diverticulitis (2013) Case Rep Gastroenterol, 7, pp. 409-413;
van der Vliet, H.J., van Bodegraven, A.A., Megacolon during treatment with lactulose (2004) Ned Tijdschr Geneeskd, 148, pp. 998-1001;
Murray, K., Wilkinson-Smith, V., Hoad, C., Differential effects of FODMAPs (fermentable oligo-, di-, mono-saccharides and polyols) on small and large intestinal contents in healthy subjects shown by MRI (2014) Am J Gastroenterol, 109, pp. 110-119;
Wilder-Smith, C.H., Olesen, S.S., Materna, A., Predictors of response to a low-FODMAP diet in patients with functional gastrointestinal disorders and lactose or fructose intolerance (2017) Aliment Pharmacol Ther, 45, pp. 1094-1106;
Rana, S.V., Malik, A., Breath tests and irritable bowel syndrome (2014) World J Gastroenterol, 20, pp. 7587-7601;
Pironi, L., Callegari, C., Cornia, G.L., Lami, G.F., Miglioli, F.M., Barbara, L., Lactose malabsorption in adult patients with Crohn's disease (1988) Am J Gastroenterol, 83, pp. 1267-1271;
Maconi, G., Ardizzone, S., Cucino, C., Bezzio, C., Russo, A.G., Bianchi Porro, G., Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study (2010) World J Gastroenterol, 16, pp. 4297-4304;
Barrett, J.S., Irving, P.M., Shepherd, S.J., Muir, J.G., Gibson, P.R., Comparison of the prevalence of fructose and lactose malabsorption across chronic intestinal disorders (2009) Aliment Pharmacol Ther, 30, pp. 165-174;
Perets, T.T., Hamouda, D., Layfer, O., Small intestinal bacterial overgrowth may increase the likelihood of lactose and sorbitol but not fructose intolerance false positive diagnosis (2017) Ann Clin Lab Sci, 47, pp. 447-451;
Shah, A., Morrison, M., Burger, D., Systematic review with meta-analysis: the prevalence of small intestinal bacterial overgrowth in inflammatory bowel disease (2019) Aliment Pharmacol Ther, 49, pp. 624-635;
Annese, V., Bassotti, G., Napolitano, G., Usai, P., Andriulli, A., Vantrappen, G., Gastrointestinal motility disorders in patients with inactive Crohn's disease (1997) Scand J Gastroenterol, 32, pp. 1107-1117;
Madrid, A.M., Poniachik, J., Quera, R., Defilippi, C., Small intestinal clustered contractions and bacterial overgrowth: a frequent finding in obese patients (2011) Dig Dis Sci, 56, pp. 155-160;
Saegesser, F., Sandblom, P., Ischemic lesions of the distended colon. A complication of obstructive colorectal cancer (1975) Am J Surg, 129, pp. 309-315;
Dencker, H., Lingårdh, G., Muth, T., Olin, T., Massive gangrene of the colon secondary to carcinoma of the rectum. Case report (1969) Acta Chir Scand, 135, pp. 357-361;
Boley, S.J., Agrawal, G.P., Warren, A.R., Pathophysiologic effects of bowel distension on intestinal blood flow (1969) Am J Surg, 117, pp. 228-234;
Lunderquist, A., Lunderquist, A., Knutsson, H., Angiography in Crohn's disease of the small bowel and colon (1967) Am J Roentgenol Radium Ther Nucl Med, 101, pp. 338-344;
Ong, D.K., Mitchell, S.B., Barrett, J.S., Manipulation of dietary short chain carbohydrates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome (2010) J Gastroenterol Hepatol, 25, pp. 1366-1373;
Spiller, R., Lam, C., The shifting interface between IBS and IBD (2011) Curr Opin Pharmacol, 11, pp. 586-592;
Gracie, D.J., Ford, A.C., Functional bowel symptoms in quiescent inflammatory bowel disease: more than just irritable bowel syndrome? (2014) Gastroenterology, 147, pp. 1176-1177;
Ritchie, J., Pain from distension of the pelvic colon by inflating a balloon in the irritable colon syndrome (1973) Gut, 14, pp. 125-132;
Whitehead, W.E., Holtkotter, B., Enck, P., Tolerance for rectosigmoid distention in irritable bowel syndrome (1990) Gastroenterology, 98, pp. 1187-1192;
Mertz, H., Naliboff, B., Munakata, J., Niazi, N., Mayer, E.A., Altered rectal perception is a biological marker of patients with irritable bowel syndrome (1995) Gastroenterology, 109, pp. 40-52;
Schmulson, M., Chang, L., Naliboff, B., Lee, O.Y., Mayer, E.A., Correlation of symptom criteria with perception thresholds during rectosigmoid distension in irritable bowel syndrome patients (2000) Am J Gastroenterol, 95, pp. 152-156;
Bouin, M., Plourde, V., Boivin, M., Rectal distention testing in patients with irritable bowel syndrome: sensitivity, specificity, and predictive values of pain sensory thresholds (2002) Gastroenterology, 122, pp. 1771-1777;
Azpiroz, F., Bouin, M., Camilleri, M., Mechanisms of hypersensitivity in IBS and functional disorders (2007) Neurogastroenterol Motil, 19, pp. 62-88;
Rao, S.S.C., Read, N.W., Davison, P.A., Bannister, J.J., Holdsworth, C.D., Anorectal sensitivity and responses to rectal distention in patients with ulcerative colitis (1987) Gastroenterology, 93, pp. 1270-1275;
van Hoboken, E.A., Thijssen, A.Y., Verhaaren, R., Symptoms in patients with ulcerative colitis in remission are associated with visceral hypersensitivity and mast cell activity (2011) Scand J Gastroenterol, 46, pp. 981-987;
Chang, L., Munakata, J., Mayer, E.A., Perceptual responses in patients with inflammatory and functional bowel disease (2000) Gut, 47, pp. 497-505;
Swarbrick, E.T., Hegarty, J.E., Bat, L., Williams, C.B., Dawson, A.M., Site of pain from the irritable bowel (1980) Lancet, 2 (8192), pp. 443-446;
Bassotti, G., Gaburri, M., Imbimbo, B.P., Morelli, A., Whitehead, W.E., Distension-stimulated propagated contractions in human colon (1994) Dig Dis Sci, 39, pp. 1955-1960;
Kantor, J.L., Colon studies IV. Theroentgenosis of colitis(the irritable colon) (1927) Am J Roentennol and Radium Therapy, 4, pp. 405-416;
Kruse, F.H., Functional disorders of the colon: the spastic colon, the irritable colon, and mucous colitis (1933) Cal West Med, 39, pp. 97-103;
Connell, A.M., Jones, F.A., Rowlands, E.N., Motility of the pelvic colon. IV. Abdominal pain associated with colonic hypermotility after meals (1965) Gut, 6, pp. 105-112;
Grimes, D.S., Refined carbohydrate, smooth-muscle spasm and disease of the colon (1976) Lancet, 1 (7956), pp. 395-397;
Harvey, R.F., Colonic motility in proctalgia fugax (1979) Lancet, 2 (8145), pp. 713-714;
Poynard, T., Regimbeau, C., Benhamou, Y., Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome (2001) Aliment Pharmacol Ther, 15, pp. 355-361;
Wakefield, A.J., Sawyerr, A.M., Dhillon, A.P., Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction (1989) Lancet, 2 (8671), pp. 1057-1062;
Wakefield, A.J., Sankey, E.A., Dhillon, A.P., Granulomatous vasculitis in Crohn's disease (1991) Gastroenterology, 100 (5), pp. 1279-1287;
Anthony, A., Dhillon, A.P., Pounder, R.E., Wakefield, A.J., Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy (1997) J Clin Pathol, 50, pp. 1013-1017;
Anthony, A., Pounder, R.E., Dhillon, A.P., Wakefield, A.J., Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat (2000) Aliment Pharmacol Ther, 14, pp. 241-245;
Koukoulis, G., Ke, Y., Henley, J.D., Cummings, O.W., Obliterative muscularization of the small bowel submucosa in Crohn disease: a possible mechanism of small bowel obstruction (2001) Arch Pathol Lab Med, 125, pp. 1331-1334;
Lineback, P.E., Studies on the musculature of human colon, with special reference to the taeniae (1925) Am J Anat, 36, pp. 357-383;
Hulten, L., Lindhagen, J., Lundgren, O., Fasth, S., Ahrén, C., Regional intestinal blood flow in Ulcerative colitis and Crohn's disease (1977) Gastroenterology, 72, pp. 388-396;
Guslandi, M., Polli, D., Sorghi, M., Tittobello, A., Rectal blood flow in ulcerative colitis (1995) Am J Gastroenterol, 90, pp. 579-580;
Tateishi, S., Arima, S., Futami, K., Assessment of blood flow in the small intestine by laser Doppler flowmetry: comparison of healthy small intestine and small intestine in Crohn's disease (1997) J Gastroenterol, 32, pp. 457-463;
Argenzio, R.A., Meulen, D.J., Short-chain fatty acids induce reversible injury of porcine colon (1991) Dig Dis Sci, 36, pp. 1459-1468;
Goldstein, R., Braverman, D., Stankiewicz, H., Carbohydrate malabsorption and the effect of dietary restriction on symptoms of irritable bowel syndrome and functional bowel complaints (2000) Isr Med Assoc J, 2, pp. 583-587;
Ringel-Kulka, T., Choi, C.H., Temas, D., Altered colonic bacterial fermentation as a potential pathophysiological factor in irritable bowel syndrome (2015) Am J Gastroenterol, 110, pp. 1339-1346;
Nugent, S.G., Kumar, D., Rampton, D.S., Evans, D.F., Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs (2001) Gut, 48, pp. 571-577;
Sasaki, Y., Hada, R., Nakajima, H., Fukuda, S., Munakata, A., Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: colonic luminal pH in normal subjects and patients with Crohn's disease (1997) Am J Gastroenterol, 92, pp. 114-118;
Macfarlane, G.T., Steed, H., Macfarlane, S., Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics (2008) J Appl Microbiol, 104, pp. 305-344;
Hua, S., Marks, E., Schneider, J.J., Keely, S., Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue (2015) Nanomedicine, 11, pp. 1117-1132;
Cummings, J.H., Macfarlane, G.T., Englyst, H.N., Prebiotic digestion and fermentation (2001) Am J Clin Nutr, 73, pp. 415S-420S;
Bovee-Oudenhoven, I.M., ten Bruggencate, S.J., Lettink-Wissink, M.L., van der Meer, R., Dietary fructo-oligosaccharides and lactulose inhibit intestinal colonisation but stimulate translocation in rats (2003) Gut, 52, pp. 1572-1578;
Chen, B.R., Du, L.J., He, H.Q., Fructo-oligosaccharide intensifies visceral hypersensitivity and intestinal inflammation in a stress-induced irritable bowel syndrome mouse model (2017) World J Gastroenterol, 23, pp. 8321-8333;
Wasan, H.S., Goodlad, R.A., Fibre-supplemented foods may damage your health (1996) Lancet, 348, pp. 319-320;
Singh, V., Yeoh, B.S., Chassaing, B., Dysregulated microbial fermentation of soluble fiber induces cholestatic liver cancer (2018) Cell, 175, pp. 679-694;
Guo, F.F., Yu, T.C., Hong, J., Fang, J.Y., Emerging roles of hydrogen sulfide in inflammatory and neoplastic colonic diseases (2016) Front Physiol, 7, p. 156;
Smith, N.W., Shorten, P.R., Altermann, E.H., Roy, N.C., McNabb, W.C., Hydrogen cross-feeders of the human gastrointestinal tract (2019) Gut Microbes, 18, pp. 270-288;
Pitcher, M.C., Cummings, J.H., Hydrogen sulphide: a bacterial toxin in ulcerative colitis? (1996) Gut, 39, pp. 1-4;
Fiorucci, S., Distrutti, E., Cirino, G., Wallace, J.L., The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver (2006) Gastroenterology, 131, pp. 259-271;
Ijssennagger, N., van der Meer, R., van Mil, S.W.C., Sulfide as a mucus barrier-breaker in inflammatory bowel disease? (2016) Trends Mol Med, 22, pp. 190-199;
Baskar, R., Bian, J., Hydrogen sulfide gas has cell growth regulatory role (2011) Eur J Pharmacol, 656, pp. 5-9;
Roediger, W.E., Duncan, A., Kapaniris, O., Millard, S., Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis (1993) Gastroenterology, 104, pp. 802-809;
Pitcher, M.C., Beatty, E.R., Cummings, J.H., The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis (2000) Gut, 46, pp. 64-72;
Zhang, L., Song, J., Hou, X., Mast cells and irritable bowel syndrome: from the bench to the bedside (2016) J Neurogastroenterol Motil, 22, pp. 181-192;
Barbara, G., Stanghellini, V., De Giorgio, R., Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome (2004) Gastroenterology, 126, pp. 693-702;
Mekkel, G., Barta, Z., Ress, Z., Gyimesi, E., Sipka, S., Zeher, M., Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases (2005) Orv Hetil, 146, pp. 797-802;
Ravnefjord, A., Pettersson, M., Rehnström, E., Martinez, V., Acute colonic ischaemia in rats results in long-term structural changes without alterations of colonic sensitivity (2008) Int J Exp Pathol, 89, pp. 476-489;
De Schepper, H.U., De Man, J.G., Moreels, T.G., Pelckmans, P.A., De Winter, B.Y., Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease– clinical relevance and pathophysiological mechanisms (2008) Aliment Pharmacol Ther, 27, pp. 621-637;
Rampton, D.S., Murdoch, R.D., Sladen, G.E., Rectal mucosal histamine release in ulcerative colitis (1980) Clin Sci (Lond), 59, pp. 389-391;
Baenkler, H.W., Lux, G., Günthner, R., Kohlhäufl, M., Matek, W., Biopsy histamine in ulcerative colitis and Crohn's disease (1987) Hepatogastroenterology, 34, pp. 289-290;
Zhang, J.M., An, J., Cytokines, inflammation, and pain (2007) Int Anesthesiol Clin, 45, pp. 27-37;
Cenac, N., Andrews, C.N., Holzhausen, M., Role for protease activity in visceral pain in irritable bowel syndrome (2007) J Clin Invest, 117, pp. 636-647;
Holzer, P., TRP channels in the digestive system (2011) Curr Pharm Biotechnol, 12, pp. 24-34;
van Wanrooij, S.J., Wouters, M.M., Van Oudenhove, L., Sensitivity testing in irritable bowel syndrome with rectal capsaicin stimulations: role of TRPV1 upregulation and sensitization in visceral hypersensitivity? (2014) Am J Gastroenterol, 109, pp. 99-109;
Akbar, A., Yiangou, Y., Facer, P., Walters, J.R., Anand, P., Ghosh, S., Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain (2008) Gut, 57, pp. 923-929;
Akbar, A., Yiangou, Y., Facer, P., Expression of the TRPV1 receptor differs in quiescent inflammatory bowel disease with or without abdominal pain (2010) Gut, 59, pp. 767-774;
Tominaga, M., Caterina, M.J., Malmberg, A.B., The cloned capsaicin receptor integrates multiple pain-producing stimuli (1998) Neuron, 21, pp. 531-543;
Jordt, S.E., Tominaga, M., Julius, D., Acid potentiation of the capsaicin receptor determined by a key extracellular site (2000) Proc Natl Acad Sci USA, 97, pp. 8134-8819;
Matsumoto, K., Kurosawa, E., Terui, H., Localization of TRPV1 and contractile effect of capsaicin in mouse large intestine: high abundance and sensitivity in rectum and distal colon (2009) Am J Physiol Gastrointest Liver Physiol, 297, pp. G348-G360;
van Diest, S.A., Stanisor, O.I., Boeckxstaens, G.R., de Jonge, W.J., van den Wijngaard, R.M., Relevance of mast cell-nerve interactions in intestinal nociception (1822) Biochim Biophys Acta, 2012, pp. 74-84;
Camilleri, M., Oduyebo, I., Halawi, H., Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions (2016) Am J Physiol Gastrointest Liver Physiol, 311, pp. G777-G784;
Zhou, Q., Zhang, B., Verne, G.N., Intestinal membrane permeability and hypersensitivity in the irritable bowel syndrome (2009) Pain, 146, pp. 41-46;
Pastor Rojo, O., López San Román, A., Albéniz Arbizu, E., Serum lipopolysaccharide-binding protein in endotoxemic patients with inflammatory bowel disease (2007) Inflamm Bowel Dis, 13, pp. 269-277;
Oriishi, T., Sata, M., Toyonaga, A., Sasaki, E., Tanikawa, K., Evaluation of intestinal permeability in patients with inflammatory bowel disease using lactulose and measuring antibodies to lipid A (1995) Gut, 36, pp. 891-896;
Buning, C., Geissler, N., Prager, M., Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease? (2012) Inflamm Bowel Dis, 18, pp. 1932-1939;
Vivinus-Nébot, M., Frin-Mathy, G., Bzioueche, H., Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation (2014) Gut, 63, pp. 744-752;
Zhou, S.Y., Gillilland, M., 3rd, Wu, X., FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction (2018) J Clin Invest, 128, pp. 267-280;
Drewe, J., Beglinger, C., Fricker, G., Effect of ischemia on intestinal permeability of lipopolysaccharides (2001) Eur J Clin Invest, 31, pp. 138-144
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070226738&doi=10.1016%2fj.mehy.2019.109324&partnerID=40&md5=a74ba3687adb012f329ac85d675ee253
ER  -

TY  - JOUR
TI  - Does symptom activity explain psychological differences in patients with irritable bowel syndrome and inflammatory bowel disease? Results from a multi-center cross-sectional study
T2  - Journal of Psychosomatic Research
J2  - J. Psychosom. Res.
VL  - 126
PY  - 2019
DO  - 10.1016/j.jpsychores.2019.109836
SN  - 00223999 (ISSN)
AU  - Berens, S.
AU  - Schaefert, R.
AU  - Baumeister, D.
AU  - Gauss, A.
AU  - Eich, W.
AU  - Tesarz, J.
AD  - Institute of Psychology, Heidelberg University, Hauptstraße 47-51, Heidelberg, D-69117, Germany
AD  - Department of General Internal Medicine and Psychosomatics, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, D-69120, Germany
AD  - Department of Psychosomatic Medicine, Division of Internal Medicine, University Hospital Basel, Hebelstrasse 2, Basel, CH-4031, Switzerland
AD  - Faculty of Medicine, University of Basel, Klingelbergstrasse 61, Basel, CH-4056, Switzerland
AD  - Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Im Neuenheimer Feld 410, Heidelberg, D-69120, Germany
AB  - Objective: Irritable bowel syndrome (IBS) and inflammatory bowel diseases (IBD) have similar symptoms and are affected by psychological factors via gut-brain-interactions. However, previous studies on IBS and IBD showed inconsistent results regarding psychological factors, potentially because they failed to consider the impact of symptom activity. The aim of this study was 1) to compare psychological distress and psychological risk factors among patients with IBS, IBD and healthy controls (HC), and 2) to assess the impact of symptom activity. Methods: A controlled cross-sectional study was conducted. Patients with IBS and IBD were recruited in several primary, secondary, and tertiary medical care units between 02 and 12/2017 in Germany. Overall, 381 matched participants (127/group, 63% female) were included. For the second analyses, patients with IBD were distinguished in patients with active (n = 93) and non-active (n = 34) symptoms. Psychological distress (somatization, depression, anxiety, and illness anxiety) and risk factors (adverse childhood experiences, attachment style, and mentalizing capacity) were measured. Results: Patients with IBS showed higher psychological distress and more psychological risk factors than patients with IBD and HC. However, patients with IBD and active symptoms showed similar psychological distress than patients with IBS, except for lower illness anxiety (p &lt; .001, η2 = 0.069). Conclusion: With the exception of higher illness anxiety in IBS patients, differences in psychological factors between patients with IBS and IBD were more strongly associated with symptom activity than with the underlying diagnosis. Therefore, this study challenges previous concepts of distinguishing functional and organic gastrointestinal diseases, but highlights the role of symptom activity and illness anxiety. Trial registration: DRKS00011685. © 2019 Elsevier Inc.
KW  - Adverse childhood experiences
KW  - Attachment
KW  - Illness anxiety
KW  - Irritable bowel syndrome
KW  - Mentalizing
KW  - Somatic symptom disorder
KW  - adult
KW  - anxiety
KW  - Article
KW  - controlled study
KW  - cross-sectional study
KW  - depression
KW  - distress syndrome
KW  - female
KW  - gastrointestinal disease
KW  - human
KW  - inflammatory bowel disease
KW  - irritable colon
KW  - major clinical study
KW  - male
KW  - mentalization
KW  - multicenter study
KW  - personal experience
KW  - psychological aspect
KW  - risk factor
KW  - symptom
KW  - tertiary health care
PB  - Elsevier Inc.
N1  - Export Date: 18 November 2019
M3  - Article
DB  - Scopus
C7  - 109836
N1  - CODEN: JPCRA
C2  - 31627144
LA  - English
N1  - Correspondence Address: Berens, S.; Institute of Psychology, Heidelberg University, Hauptstraße 47-51, Germany; email: Sabrina.Berens@med.uni-heidelberg.de
N1  - Funding details: S0112/10209/16
N1  - Funding text 1: This study was funded by the Köhler-Stiftung (grant number: S0112/10209/16 ). They had no role in the study design, the collection, analysis and interpretation of data, the writing of the manuscript or in the decision to submit the article for publication. We would like to thank the participating clinicians and patients. Appendix A
N1  - References: Canavan, C., West, J., Card, T., The epidemiology of irritable bowel syndrome (2014) Clin. Epidemiol., 6, p. 71;
Soares, R.L., Irritable bowel syndrome: a clinical review (2014) World J. Gastroenterol., 20 (34);
Canavan, C., West, J., Card, T., The economic impact of the irritable bowel syndrome (2014) Aliment. Pharmacol. Ther., 40 (9), pp. 1023-1034;
Sperber, A.D., Dumitrascu, D., Fukudo, S., Gerson, C., Ghoshal, U.C., Gwee, K.A., The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome foundation working team literature review (2016) Gut., 2015, p. 311240. , gutjnl;
Agarwal, N., Spiegel, B.M., The effect of irritable bowel syndrome on health-related quality of life and health care expenditures (2011) Gastroenterol. Clin., 40 (1), pp. 11-19;
Drossman, D.A., Functional gastrointestinal disorders: history, pathophysiology, clinical features, and Rome IV (2016) Gastroenterology, 150 (6), pp. 1262-1279. , (e2);
Drossman, D.A., Hasler, W.L., Rome IV—functional GI disorders: disorders of gut-brain interaction (2016) Gastroenterology, 150 (6), pp. 1257-1261;
Oudenhove, L.V., Crowell, M., Drossman, D., Halpert, A., Keefer, L., Lackner, J., Biopsychosocial aspects of functional gastrointestinal disorders (2016) Gastroenterology, 150, pp. 1355-1367;
Loftus, E.V., Jr., Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences (2004) Gastroenterology, 126 (6), pp. 1504-1517;
Burisch, J., Jess, T., Martinato, M., Lakatos, P.L., ECCO-EpiCom, The burden of inflammatory bowel disease in Europe (2013) J. Crohn's Colitis, 7 (4), pp. 322-337;
Gracie, D.J., Guthrie, E.A., Hamlin, P.J., Ford, A.C., Bi-directionality of brain–gut interactions in patients with inflammatory bowel disease (2018) Gastroenterology, 154 (6), pp. 1635-1646. , (e3);
Walker, E.A., Roy-Byrne, P.P., Katon, W.J., Li, L., Amos, D., Jiranek, G., Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease (1990) Am. J. Psychiatry, 147 (12), p. 1656;
Schwarz, S.P., Blanchard, E.B., Berreman, C.F., Scharff, L., Taylor, A.E., Greene, B.R., Psychological aspects of irritable bowel syndrome: comparisons with inflammatory bowel disease and nonpatient controls (1993) Behav. Res. Ther., 31 (3), pp. 297-304;
Kovács, Z., Kovács, F., Depressive and anxiety symptoms, dysfunctional attitudes and social aspects in irritable bowel syndrome and inflammatory bowel disease (2007) Int. J. Psychiatry Med., 37 (3), pp. 245-255;
Jones, M.P., Wessinger, S., Crowell, M.D., Coping strategies and interpersonal support in patients with irritable bowel syndrome and inflammatory bowel disease (2006) Clin. Gastroenterol. Hepatol., 4 (4), pp. 474-481;
Pace, F., Molteni, P., Bollani, S., Sarzi-Puttini, P., Stockbrügger, R., Porro, G.B., Inflammatory bowel disease versus irritable bowel syndrome: a hospital-based, case-control study of disease impact on quality of life (2003) Scand. J. Gastroenterol., 38 (10), pp. 1031-1038;
Zamani, M., Alizadeh-Tabari, S., Zamani, V., Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome (2019) Aliment. Pharmacol. Ther., 50 (2), pp. 132-143;
Mikocka-Walus, A., Knowles, S.R., Keefer, L., Graff, L., Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases (2016) Inflamm. Bowel Dis., 22 (3), pp. 752-762;
Waldinger, R.J., Schulz, M.S., Barsky, A.J., Ahern, D.K., Mapping the road from childhood trauma to adult somatization: the role of attachment (2006) Psychosom. Med., 68 (1), pp. 129-135;
Chang, L., The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome (2011) Gastroenterology, 140 (3), pp. 761-765. , (e5);
Riem, M.M., Doedée, E.N., Broekhuizen-Dijksman, S.C., Beijer, E., Attachment and medically unexplained somatic symptoms: the role of mentalization (2018) Psychiatry Res., 268, pp. 108-113;
Fonagy, P., Gergely, G., Jurist, E.L., Affect Regulation, Mentalization and the Development of the Self: Karnac books (2004); Luyten, P., Van Houdenhove, B., Lemma, A., Target, M., Fonagy, P., A mentalization-based approach to the understanding and treatment of functional somatic disorders (2012) Psychoanal. Psychother., 26 (2), pp. 121-140;
Gracie, D.J., Hamlin, P.J., Ford, A.C., The influence of the brain–gut axis in inflammatory bowel disease and possible implications for treatment (2019) Lancet Gastroenterol. Hepatol., 4 (8), pp. 632-642;
Chitkara, D.K., Van Tilburg, M.A., Blois-Martin, N., Whitehead, W.E., Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review (2008) Am. J. Gastroenterol., 103 (3), p. 765;
Baccini, F., Pallotta, N., Calabrese, E., Pezzotti, P., Corazziari, E., Prevalence of sexual and physical abuse and its relationship with symptom manifestations in patients with chronic organic and functional gastrointestinal disorders (2003) Dig. Liver Dis., 35 (4), pp. 256-261;
Gerson, C., Gerson, M.J., Chang, L., Corazziari, E., Dumitrascu, D., Ghoshal, U., A cross-cultural investigation of attachment style, catastrophizing, negative pain beliefs, and symptom severity in irritable bowel syndrome (2015) Neurogastroenterol. Motil., 27 (4), pp. 490-500;
Bengtsson, M., Sjöberg, K., Candamio, M., Lerman, A., Ohlsson, B., Anxiety in close relationships is higher and self-esteem lower in patients with irritable bowel syndrome compared to patients with inflammatory bowel disease (2013) Eur. J. Intern. Med., 24 (3), pp. 266-272;
Agostini, A., Rizzello, F., Ravegnani, G., Gionchetti, P., Tambasco, R., Straforini, G., Adult attachment and early parental experiences in patients with Crohn's disease (2010) Psychosomatics, 51 (3), pp. 208-215;
Agostini, A., Spuri Fornarini, G., Ercolani, M., Campieri, M., Attachment and perceived stress in patients with ulcerative colitis, a case–control study (2016) J. Psychiatr. Ment. Health Nurs., 23 (9-10), pp. 561-567;
Farnam, A., Somi, M.H., Farhang, S., Mahdavi, N., Besharat, M.A., The therapeutic effect of adding emotional awareness training to standard medical treatment for irritable bowel syndrome: a randomized clinical trial (2014) J. Psychiatr. Pract., 20 (1), pp. 3-11. , ®;
Porcelli, P., De Carne, M., Leandro, G., The role of alexithymia and gastrointestinal-specific anxiety as predictors of treatment outcome in irritable bowel syndrome (2017) Compr. Psychiatry, 73, pp. 127-135;
Faramarzi, M., Shokri-Shirvani, J., Kheirkhah, F., Kianian, M., Ghadiri, M., Comparison of psychological factors in patients with irritable bowel syndrome and inflammatory bowel diseases (2015) Br. J. Med. Med. Res., 5 (2), p. 213;
Viganò, C.A., Beltrami, M.M., Bosi, M.F., Zanello, R., Valtorta, M., Maconi, G., Alexithymia and psychopathology in patients with inflammatory bowel disease: arising differences and correlations to tailoring therapeutic strategies (2018) Front. Psychiatry., 9, p. 324;
Lackner, J.M., Ma, C.X., Keefer, L., Brenner, D.M., Gudleski, G.D., Satchidanand, N., Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome (2013) Clin. Gastroenterol. Hepatol., 11 (9), pp. 1147-1157;
Torkzadeh, F., Danesh, M., Mirbagher, L., Daghaghzadeh, H., Emami, M.H., Relations between coping skills, symptom severity, psychological symptoms, and quality of life in patients with irritable bowel syndrome (2019) Int. J. Prev. Med., 10;
Naliboff, B.D., Kim, S.E., Bolus, R., Bernstein, C.N., Mayer, E.A., Chang, L., Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis (2012) Am. J. Gastroenterol., 107 (3), p. 451;
Graff, L.A., Walker, J.R., Bernstein, C.N., Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management (2009) Inflamm. Bowel Dis., 15 (7), pp. 1105-1118;
Byrne, G., Rosenfeld, G., Leung, Y., Qian, H., Raudzus, J., Nunez, C., Prevalence of anxiety and depression in patients with inflammatory bowel disease (2017) Can. J. Gastroenterol. Hepatol., 2017;
Häuser, W., Janke, K.-H., Klump, B., Hinz, A., Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population (2010) Inflamm. Bowel Dis., 17 (2), pp. 621-632;
Caplan, R.A., Maunder, R.G., Stempak, J.M., Silverberg, M.S., Hart, T.L., Attachment, childhood abuse, and IBD-related quality of life and disease activity outcomes (2014) Inflamm. Bowel Dis., 20 (5), pp. 909-915;
Maunder, R.G., Lancee, W.J., Hunter, J.J., Greenberg, G.R., Steinhart, H.A., Attachment insecurity moderates the relationship between disease activity and depressive symptoms in ulcerative colitis (2005) Inflamm. Bowel Dis., 11 (10), pp. 919-926;
Geiss, T., Schaefert, R.M., Berens, S., Hoffmann, P., Gauss, A., Risk for depression in patients with inflammatory bowel diseases (2018) J. Dig. Dis., 19 (8), pp. 456-467;
Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F., Spiller, R.C., Functional bowel disorders (2006) Gastroenterology, 130 (5), pp. 1480-1491;
Clara, I., Lix, L.M., Walker, J.R., Graff, L.A., Miller, N., Rogala, L., The Manitoba IBD index: evidence for a new and simple indicator of IBD activity (2009) Am. J. Gastroenterol., 104 (7), p. 1754;
Leiner, D., SoSci survey, (2014), https://wwwsoscisurveyde, access; Charlson, M.E., Pompei, P., Ales, K.L., MacKenzie, C.R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation (1987) J. Chronic Dis., 40 (5), pp. 373-383;
Francis, C.Y., Morris, J., Whorwell, P.J., The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress (1997) Aliment. Pharmacol. Ther., 11 (2), pp. 395-402;
Betz, C., Mannsdörfer, K., Bischoff, S., Validation of the IBS-SSS (2013) Z. Gastroenterol., 51 (10), pp. 1171-1176;
EuroQol, G., EuroQol--a new facility for the measurement of health-related quality of life (1990) Health Policy (Amsterdam, Netherlands)., 16 (3), p. 199;
Schulenburg, J., Graf von der, Claes, C., Greiner, W., Uber, A., Die deutsche version des Euroqol-fragebogens (1998) Z. Gesundheitswissenschaft., 6, pp. 3-20;
Bushnell, D.M., Martin, M.L., Ricci, J.F., Bracco, A., Performance of the EQ-5D in patients with irritable bowel syndrome (2006) Value Health, 9 (2), pp. 90-97;
Stark, R.G., Reitmeir, P., Leidl, R., König, H.H., Validity, reliability, and responsiveness of the EQ-5D in inflammatory bowel disease in Germany (2010) Inflamm. Bowel Dis., 16 (1), pp. 42-51;
Heuft, G., Senf, W., Bell, K., Cording, C., Geyer, M., Janssen, P., L., Lamprecht, F., Wirsching, M., Psy-BaDo. Kernmodul einer Basisdokumentation in derFachpsychotherapie (1998) Psychotherapeut, 43 (1), pp. 48-52;
Gierk, B., Kohlmann, S., Kroenke, K., Spangenberg, L., Zenger, M., Brahler, E., The somatic symptom scale-8 (SSS-8): a brief measure of somatic symptom burden (2014) JAMA Intern. Med., 174 (3), pp. 399-407;
Kroenke, K., Spitzer, R.L., Williams, J.B., The PHQ-9: validity of a brief depression severity measure (2001) J. Gen. Intern. Med., 16 (9), pp. 606-613;
Löwe, B., Spitzer, R., Zipfel, S., Herzog, W., PHQ-D–Gesundheitsfragebogen für Patienten, Manual–komplettversion und kurzform–autorisierte deutsche version des “prime MD Patient Health Questionnaire (PHQ)” (2002) Patient Health Questionnaire, Manual—full and Short Version—Authorized German Version of the Prime MD Patient Health Questinnaire (PHQ), , Pfizer Heidelberg;
Boeckxstaens, G.E., Drug, V., Dumitrascu, D., Farmer, A.D., Hammer, J., Hausken, T., Phenotyping of subjects for large scale studies on patients with IBS (2016) Neurogastroenterol. Motil., 28 (8), pp. 1134-1147;
Spitzer, R.L., Kroenke, K., Williams, J.B., Lowe, B., A brief measure for assessing generalized anxiety disorder: the GAD-7 (2006) Arch. Intern. Med., 166 (10), pp. 1092-1097;
Fink, P., Ewald, H., Jensen, J., Sorensen, L., Engberg, M., Holm, M., Screening for somatization and hypochondriasis in primary care and neurological in-patients: a seven-item scale for hypochondriasis and somatization (1999) J. Psychosom. Res., 46 (3), pp. 261-273;
Hiller, W., Rief, W., Internationale Skalen für Hypochondrie: Deutschsprachige Adaption des Whiteley-Index (WI) und Illness Attitude Scales (IAS) (2004), Verlag Hans Huber; Felitti, V.J., Anda, R.F., Nordenberg, D., Williamson, D.F., Spitz, A.M., Edwards, V., Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the adverse childhood experiences (ACE) study (1998) Am. J. Prev. Med., 14 (4), pp. 245-258;
Wingenfeld, K., Schäfer, I., Terfehr, K., Grabski, H., Driessen, M., Grabe, H., Reliable, valide und ökonomische erfassung früher traumatisierung: erste psychometrische charakterisierung der deutschen version des Adverse Childhood Experiences questionnaire (ACE) (2011) PPmP-Psychother. Psychosom. Med. Psychol., 61 (1), pp. e10-e14;
Park, S.H., Videlock, E.J., Shih, W., Presson, A.P., Mayer, E.A., Chang, L., Adverse childhood experiences are associated with irritable bowel syndrome and gastrointestinal symptom severity (2016) Neurogastroenterol. Motil., 28 (8), pp. 1252-1260;
Brennan, K.A., Clark, C.L., Shaver, P.R., Self-Report Measurement of Adult Attachment: an Integrative Overview (1998); Ehrenthal, J.C., Dinger, U., Lamla, A., Funken, B., Schauenburg, H., Evaluation der deutschsprachigen version des bindungsfragebogens “Experiences in Close Relationships-Revised” (ECR-RD) (2009) Psychother. Psychosom. Med. Psychol., 59, pp. 315-323;
Hausberg, M.C., Schulz, H., Piegler, T., Happach, C.G., Klöpper, M., Brütt, A.L., Is a self-rated instrument appropriate to assess mentalization in patients with mental disorders? Development and first validation of the Mentalization questionnaire (MZQ) (2012) Psychother. Res., 22 (6), pp. 699-709;
Wacholder, S., McLaughlin, J.K., Silverman, D.T., Mandel, J.S., Selection of controls in case-control studies: i. principles (1992) Am. J. Epidemiol., 135 (9), pp. 1019-1028;
Benjamini, Y., Hochberg, Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing (1995) J. R. Stat. Soc. Ser. B Methodol., 57 (1), pp. 289-300;
Kroenke, K., Spitzer, R.L., Williams, J.B., Löwe, B., The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review (2010) Gen. Hosp. Psychiatry, 32 (4), pp. 345-359;
Cohen, J., Statistical Power Analysis for the Behavioral Sciences (1988), 2nd Erlbaum Hillsdale, NJ; Mikocka-Walus, A.A., Turnbull, D.A., Moulding, N.T., Wilson, I.G., Andrews, J.M., Holtmann, G.J., Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: a literature review (2007) Inflamm. Bowel Dis., 13 (2), pp. 225-234;
Koloski, N., Jones, M., Talley, N., Evidence that independent gut-to-brain and brain-to-gut pathways operate in the irritable bowel syndrome and functional dyspepsia: a 1-year population-based prospective study (2016) Aliment. Pharmacol. Ther., 44 (6), pp. 592-600;
Mardini, H.E., Kip, K.E., Wilson, J.W., Crohn's disease: a two-year prospective study of the association between psychological distress and disease activity (2004) Dig. Dis. Sci., 49 (3), pp. 492-497;
Mittermaier, C., Dejaco, C., Waldhoer, T., Oefferlbauer-Ernst, A., Miehsler, W., Beier, M., Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study (2004) Psychosom. Med., 66 (1), pp. 79-84;
Gwee, K., Leong, Y., Graham, C., McKendrick, M., Collins, S., Walters, S., The role of psychological and biological factors in postinfective gut dysfunction (1999) Gut., 44 (3), pp. 400-406;
Löwe, B., Lohse, A., Andresen, V., Vettorazzi, E., Rose, M., Broicher, W., The development of irritable bowel syndrome: a prospective community-based cohort study (2016) Am. J. Gastroenterol., 111 (9), p. 1320;
Nicholl, B., Halder, S., Macfarlane, G., Thompson, D., O'brien, S., Musleh, M., Psychosocial risk markers for new onset irritable bowel syndrome–results of a large prospective population-based study (2008) PAIN, 137 (1), pp. 147-155. , ®;
Gomborone, J., Dewsnap, P., Libby, G., Farthing, M., Abnormal illness attitudes in patients with irritable bowel syndrome (1995) J. Psychosom. Res., 39 (2), pp. 227-230;
Craske, M.G., Wolitzky-Taylor, K.B., Labus, J., Wu, S., Frese, M., Mayer, E.A., A cognitive-behavioral treatment for irritable bowel syndrome using interoceptive exposure to visceral sensations (2011) Behav. Res. Ther., 49 (6-7), pp. 413-421;
Garland, E.L., Gaylord, S.A., Palsson, O., Faurot, K., Mann, J.D., Whitehead, W.E., Therapeutic mechanisms of a mindfulness-based treatment for IBS: effects on visceral sensitivity, catastrophizing, and affective processing of pain sensations (2012) J. Behav. Med., 35 (6), pp. 591-602;
Gaylord, S.A., Palsson, O.S., Garland, E.L., Faurot, K.R., Coble, R.S., Mann, J.D., Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial (2011) Am. J. Gastroenterol., 106 (9), pp. 1678-1688;
Targownik, L.E., Sexton, K.A., Bernstein, M.T., Walker, J.R., Graff, L.A., Miller, N., Tu1116 the association between symptom burden and inflammatory activity in IBD (2013) Gastroenterology, 144 (5), pp. S-766;
Halpin, S.J., Ford, A.C., Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis (2012) Am. J. Gastroenterol., 107 (10);
Long, M.D., Drossman, D.A., Inflammatory bowel disease, irritable bowel syndrome, or what?: a challenge to the functional–organic dichotomy (2010) Nat. Publ. Group, 105 (8), pp. 1796-1798;
Farrokhyar, F., Marshall, J.K., Easterbrook, B., Irvine, E.J., Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health (2006) Inflamm. Bowel Dis., 12 (1), pp. 38-46;
Association AAP, Diagnostic and Statistical Manual of Mental Disorders (DSM-5®) (2013), American Psychiatric PubUR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85073159216&doi=10.1016%2fj.jpsychores.2019.109836&partnerID=40&md5=32798524bf5dd04bd262421f5015390e
ER  -

TY  - JOUR
TI  - Self-compassion and adjustment in epilepsy and psychogenic nonepileptic seizures
T2  - Epilepsy and Behavior
J2  - Epilepsy Behav.
VL  - 100
PY  - 2019
DO  - 10.1016/j.yebeh.2019.106490
SN  - 15255050 (ISSN)
AU  - Clegg, S.
AU  - Sirois, F.
AU  - Reuber, M.
AD  - Clinical Psychology Unit, University of Sheffield, Ireland
AD  - Department of Psychology, University of Sheffield, Ireland
AD  - Academic Neurology Unit, University of Sheffield, Ireland
AB  - Purpose: Self-compassion has been associated with a set of adaptive coping strategies, which in turn explain better adjustment in individuals with chronic illnesses such as inflammatory bowel disease and arthritis. The aim of this study was to investigate whether self-compassion is associated with adjustment in people with epilepsy (PWE) and people with psychogenic nonepileptic seizures (PWPNES). Adjustment was measured via coping efficacy, quality of life (QoL), anxiety, and depression. Method: A cross-sectional questionnaire design was employed. People with epilepsy (N = 74), PWPNES (N = 46), and controls (N = 89), recruited from outpatient seizure clinics and online, completed questionnaires about their self-compassion, coping efficacy, QoL, anxiety, and depression levels. Results: Overall, self-compassion was associated with adjustment in PWE and PWPNES. Self-compassion was negatively related to anxiety and depression in PWE, PWPNES, and controls and positively related to coping efficacy in PWE and PWPNES. Self-compassion was also positively related to QoL in PWE and controls; however, this relationship was not significant in PWPNES. Conclusion: Self-compassion is associated with better adjustment in PWE and PWPNES. Implications of these findings for psychotherapeutic interventions for individuals with seizure disorders and future research are discussed. © 2019 Elsevier Inc.
KW  - Anxiety
KW  - Depression
KW  - Epilepsy
KW  - PNES
KW  - Self-compassion
KW  - adult
KW  - anxiety disorder
KW  - Article
KW  - controlled study
KW  - coping behavior
KW  - cross-sectional study
KW  - depression
KW  - disease association
KW  - epilepsy
KW  - epileptic patient
KW  - female
KW  - human
KW  - major clinical study
KW  - male
KW  - patient attitude
KW  - psychogenic nonepileptic seizure
KW  - psychological adjustment
KW  - quality of life
KW  - questionnaire
KW  - self compassion
KW  - visual acuity
PB  - Academic Press Inc.
N1  - Export Date: 18 November 2019
M3  - Article
DB  - Scopus
C7  - 106490
N1  - CODEN: EBPEA
C2  - 31574429
LA  - English
N1  - Correspondence Address: Clegg, S.; Bradford District Care NHS Foundation TrustIreland; email: stephanie.clegg@bdct.nhs.uk
N1  - References: Brown, R.J., Reuber, M., Towards an integrative theory of psychogenic non-epileptic seizures (PNES) (2016) Clin Psychol Rev, 47, pp. 55-70;
Duncan, J.S., Sander, J.W., Sisodiya, S.M., Walker, M.C., Adult epilepsy (2006) Lancet, 367, pp. 1087-1100;
Pinikahana, J., Dono, J., The lived experience of initial symptoms of and factors triggering epileptic seizures (2009) Epilepsy Behav, 15, pp. 513-520;
Michaelis, R., Tang, V., Wagner, J.L., Modi, A.C., LaFrance, W.C., Jr., Goldstein, L.H., Psychological treatments for people with epilepsy (2017) Cochrane Database Syst Rev, 2017 (10), pp. 1-77;
Ramaratnam, S., Baker, G., Goldstein, L., Psychological treatments for epilepsy (2008) Cochrane Database Syst Rev, 2008 (3);
National Institute for Clinical Excellence, Epilepsies: diagnosis and management (CG137) (2012), https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#psychological-interventions, Retrieved 12.5.18 from; Hingray, C., El-Hage, W., Duncan, R., Gigineishvili, D., Kanemoto, K., LaFrance, W.C., Jr., Access to diagnostic and therapeutic facilities for psychogenic nonepileptic seizures: an international survey by the ILAE PNES Task Force (2018) Epilepsia, 59, pp. 203-214. , Cited by: 10;
La France, W., Reuber, M., Goldstein, L.H., Management of psychogenic non-epileptic seizures (2013) Epilepsia, 54, pp. 53-67;
Brown, R.J., Reuber, M., Psychological and psychiatric aspects of psychogenic non-epileptic seizures (PNES): a systematic review (2016) Clin Psychol Rev, 45, pp. 157-182;
Mayor, R., Howlett, S., Grunewald, R., Reuber, M., Long-term outcome of brief augmented psychodynamic interpersonal therapy for psychogenic nonepileptic seizures: seizure control and healthcare utilization (2010) Epilepsia, 51, pp. 1169-1176;
Reuber, M., Elger, C.E., Psychogenic nonepileptic seizures: review and update (2003) Epilepsy Behav, 4, pp. 205-216;
Diprose, W., Sundram, F., Menkes, D., Psychiatric comorbidity in psychogenic nonepileptic seizures compared with epilepsy (2016) Epilepsy Behav, 56, pp. 123-130;
Kerr, M.P., The impact of epilepsy on patients' lives (2012) Acta Neurol Scand, 126, pp. 1-9;
Dimaro, L., Roberts, N., Moghaddam, N., Dawson, D., Brown, I., Reuber, M., Implicit and explicit self-esteem discrepancies in people with psychogenic nonepileptic seizures (2015) Epilepsy Behav, 46, pp. 109-117;
Margrove, K., Mensah, S., Thapar, A., Kerr, M., Depression screening for patients with epilepsy in a primary care setting using the Patient Health Questionnaire-2 and the Neurological Disorders Depression Inventory for Epilepsy (2011) Epilepsy Behav, 21, pp. 387-390;
Bakvis, P., Spinhoven, P., Zitman, F.G., Roelofs, K., Automatic avoidance tendencies in patients with psychogenic non epileptic seizures (2011) Seizure, 20, pp. 628-634;
Dimaro, L., Dawson, D., Roberts, N., Brown, B., Moghaddam, N., Reuber, M., Anxiety and avoidance in psychogenic nonepileptic seizures: the role of implicit and explicit anxiety (2014) Epilepsy Behav, 33, pp. 77-86;
Kerr, M.P., Mensah, S., Besag, F., de Toffol, B., Ettinger, A., Kanemoto, K., International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy (2011) Epilepsia, 52, pp. 2133-2138;
Kemp, S., Morley, S., Anderson, E., Coping with epilepsy: do illness representations play a role? (1999) Br J Clin Psychol, 38, pp. 43-58;
Rosenbaum, M., Palmon, N., Helplessness and resourcefulness in coping with epilepsy (1984) J Consult Clin Psychol, 52, pp. 244-253;
Baker, D., Caswell, H., Eccles, F., Self-compassion and depression, anxiety, and resilience in adults with epilepsy (2019) Epilepsy Behav, 90, pp. 154-161;
Neff, K.D., Self-compassion: an alternative conceptualization of a healthy attitude toward oneself (2003) Self Identity, 2, pp. 85-101;
Ferrari, M., Dal Cin, M., Steele, M., Self-compassion is associated with optimum self-care behaviour, medical outcomes and psychological well-being in a cross-sectional sample of adults with diabetes (2017) Diabet Med, 34, pp. 1-8;
Sirois, F.M., Molnar, D.S., Hirsch, J.K., Self-compassion, stress, and coping in the context of chronic illness (2015) Self Identity, pp. 1-14;
Novakova, B., Harris, P.R., Ponnusamy, A., Reuber, M., The role of stress as a trigger for epileptic seizures: a narrative review of evidence from human and animal studies (2013) Epilepsia, 54, pp. 1866-1876;
Raes, F., Pommier, E., Neff, K.D., Van Gucht, D., Construction and factorial validation of a short form of the Self-Compassion Scale (2011) Clin Psychol Psychother, 18, pp. 250-255;
Gignac, M.A., Cott, C., Badley, E.M., Adaptation to chronic illness and disability and its relationship to perceptions of independence and dependence (2000) J Gerontol, 55, pp. 362-372;
Spitzer, R., Kroenke, K., Williams, J., Lowe, B., A brief measure for assessing general anxiety disorder: the GAD-7 (2006) Arch Intern Med, 166, pp. 1092-1097;
Lowe, B., Decker, O., Müller, S., Brähler, E., Schellberg, D., Herzog, W., Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population (2008) Med Care, 46, pp. 266-274;
Kroenke, K., Spitzer, R., Williams, J., The PHQ 9: validity of a brief depression severity measure (2001) J Gen Intern Med, 16, pp. 606-613;
Gilbody, S., Richards, D., Barkham, M., Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ–9 and CORE–OM (2007) Br J Gen Pract, 57, pp. 650-652. , http://bjgp.org/content/57/541/650.full, Available from:;
Sanchez-Arenas, R., Vargas-Alarcon, G., Sanchez-Garcia, S., Garcia-Peña, C., Gutierrez-Gutierrez, L., Grijalva, I., Value of EQ-5D in Mexican city older population with and without dementia (SADEM study) (2013) Int J Geriatr Psychiatry, 29, pp. 478-488;
Scott-Lennox, J., Bryant-Comstock, L., Lennox, R., Baker, G., Reliability, validity and responsiveness of a revised scoring system for the Liverpool Seizure Severity Scale (2001) Epilepsy Res, 44, pp. 53-63;
Baker, G.A., Smith, D.F., Jacoby, A., Hayes, J.A., Chadwick, D.W., Liverpool Seizure Severity Scale Revisited (1998) Seizure, 7, pp. 201-205;
Novakova, B., Harris, P., Rawlings, G., Reuber, M., Coping with stress: a pilot study of a self-help stress management intervention for patients with epileptic or psychogenic non-epileptic seizures (2019) Epilepsy Behav, 94, pp. 169-177;
Cohen, J., Statistical power analysis for the behavioral sciences (1988), 2nd ed. Erlbaum Hillsdale, NJ; Faul, F., Erdfelder, E., Buchner, A., Lang, A.G., Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses (2009) Behav Res Methods, 41, pp. 1149-1160;
Cohen, J., A power primer (1992) Psychol Bull, 112, pp. 155-159;
Sirois, F.M., Rowse, G., The role of self-compassion in chronic illness care (2017) J Clin Outcomes, 23, pp. 521-527. , http://www.turner-white.com/pdf/jcom_nov16_compassion.pdf, Available from:;
Cullingham, T., Kirkby, A., Sellwood, W., Eccles, F., Avoidance in nonepileptic attack disorder: a systematic review and meta-analyses (2019) Epilepsy Behav, 95, pp. 100-111;
Goldstein, L.H., Drew, C., Mellers, J., Mitchell-O'Malley, S., Oakley, D., Dissociation, hypnotizability, coping styles and health locus of control: characteristics of pseudoseizure patients (2000) Seizure, 9, pp. 314-322;
Voth, J., Sirois, F.M., The role of self-blame and responsibility in adjustment to inflammatory bowel disease (2009) Rehabil Psychol, 54, pp. 99-108;
Brion, J., Leary, M., Drabkin, A., Self-compassion and reactions to serious illness: the case of HIV (2014) J Health Psychol, 19, pp. 218-229;
MacBeth, A., Gumley, A., Exploring compassion: a meta-analysis of the association between self-compassion and psychopathology (2012) Clinical Psychology Review, 32, pp. 545-552;
Pino-Gouveia, J., Duarte, C., Matos, M., Fráguas, S., The protective role of self-compassion in relation to psychopathology symptoms and quality of life in chronic illness and in cancer patients (2014) Clin Psychol Psychother, 21, pp. 311-323;
Walsh, S., Levita, L., Reuber, M., Comorbid depression and associated factors in PNES versus epilepsy: systematic review and meta-analysis (2018) Seizure, 60, pp. 44-56;
Testa, S.M., Lesser, R.P., Krauss, G.L., Brandt, J., Personality assessment inventory among patients with psychogenic seizures and those with epilepsy (2012) Eplipsia, 52;
Goldstein, L.H., Mellers, J.D., Ictal symptoms of anxiety, avoidance behaviour, and dissociation in patients with dissociative seizures (2006) J Neurol Neurosurg Psychiatry, 77, pp. 616-621;
Margolis, S., Nakhutina, L., Schaffer, S., Grant, A., Gonzalez, J., Perceived epilepsy stigma mediates relationships between personality and social well-being in a diverse epilepsy population (2018) Epilepsy Behav, 78, pp. 7-13;
Bagby, R.M., Parker, J.D.A., Taylor, G.J., The twenty-item Toronto Alexithymia Scale-I. Item selection and cross-validation of the factor structure (1994) J Psychosom Res, 38, pp. 23-32;
Reuber, M., Fernandez, G., Bauer, J., Helmstaedter, C., Elger, C.E., Diagnostic delay in psychogenic nonepileptic seizures (2002) Neurology, 58, pp. 493-495;
Karakis, I., Montouris, G., Piperidou, C., Luciano, M., Meador, K., Cole, A., Patient and caregiver quality of life in psychogenic non-epileptic seizures compared to epileptic seizures (2014) Seizure, 23, pp. 47-54;
La France, W., Alosco, M., Davis, J., Tremont, G., Ryan, C., Keitner, G., Impact of family functioning on quality of life in patients with psychogenic nonepileptic seizures versus epilepsy (2011) Epilepsia, 52, pp. 292-300;
Boellinghaus, I., Jones, F., Hutton, J., The role of mindfulness and loving-kindness mediation in cultivating self-compassion and other-focused concern in health care professionals (2014) Mindfulness, 5, pp. 129-138;
Bartels-Velthuis, A.A., Van Der Ploeg, K., Schroevers, M.J., Van Den Brink, H., The effects of a mindfulness based compassionate living training on anxiety and depression in a heterogeneous sample of psychiatric outpatients: a pilot study (2015) Eur Psychiatry, 30, pp. 628-631;
Gilbert, P., Introducing compassion focused therapy (2009) BJPsych Adv Psychiatr Treat, 15, pp. 199-208;
Gilbert, P., Procter, S., Compassionate mind training for people with high shame and self-criticism: overview and pilot study of a group therapy approach (2006) Clin Psychol Psychother, 13, pp. 353-379. , [doi: 0.1002/cpp.507];
Neff, K.D., Germer, C.K., A pilot study and randomized controlled trial of the mindful self-compassion program (2013) J Clin Psychol, 69, pp. 28-44;
Leaviss, J., Uttley, L., Psychotherapeutic benefits of compassion-focused therapy: an early systematic review (2015) Psychol Med, 45, pp. 927-945
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072655092&doi=10.1016%2fj.yebeh.2019.106490&partnerID=40&md5=47892045654d5863a254655d273632cf
ER  -

TY  - JOUR
TI  - Exercise influence on the microbiome–gut–brain axis
T2  - Gut Microbes
J2  - Gut Microbes
VL  - 10
IS  - 5
SP  - 555
EP  - 568
PY  - 2019
DO  - 10.1080/19490976.2018.1562268
SN  - 19490976 (ISSN)
AU  - Dalton, A.
AU  - Mermier, C.
AU  - Zuhl, M.
AD  - Department of Health, Exercise, and Sports Sciences, University of New Mexico, Albuquerque, NM, United States
AB  - The microbiome in the gut is a diverse environment, housing the majority of our bacterial microbes. This microecosystem has a symbiotic relationship with the surrounding multicellular organism, and a balance and diversity of specific phyla of bacteria support general health. When gut bacteria diversity diminishes, there are systemic consequences, such as gastrointestinal and psychological distress. This pathway of communication is known as the microbiome–gut–brain axis. Interventions such as probiotic supplementation that influence microbiome also improve both gut and brain disorders. Recent evidence suggests that aerobic exercise improves the diversity and abundance of genera from the Firmcutes phylum, which may be the link between the positive effects of exercise on the gut and brain. The purpose of this review is to explain the complex communication pathway of the microbiome–gut–brain axis and further examine the role of exercise on influencing this communication highway. © 2019, © 2019 Taylor & Francis Group, LLC.
KW  - brain
KW  - Exercise
KW  - gut
KW  - microbiome–gut–brain axis
KW  - probiotics
KW  - brain derived neurotrophic factor
KW  - corticotropin
KW  - high density lipoprotein
KW  - lipopolysaccharide
KW  - probiotic agent
KW  - serotonin
KW  - short chain fatty acid
KW  - Actinobacteria
KW  - anxiety
KW  - autonomic nervous system
KW  - behavior change
KW  - Bifidobacterium
KW  - Bifidobacterium longum
KW  - brain
KW  - cerebrovascular accident
KW  - cognition
KW  - depression
KW  - diet-induced obesity
KW  - distress syndrome
KW  - exercise
KW  - Firmicutes
KW  - gastrointestinal symptom
KW  - human
KW  - hypothalamus hypophysis adrenal system
KW  - immunoregulation
KW  - inflammatory bowel disease
KW  - intestine flora
KW  - Lactobacillus
KW  - microbial community
KW  - microbial diversity
KW  - microbiome
KW  - microbiome gut brain axis
KW  - neuroendocrine system
KW  - nonhuman
KW  - physical activity
KW  - protein expression
KW  - Review
KW  - schizophrenia
KW  - sugar intake
KW  - supplementation
KW  - treadmill exercise
PB  - Taylor and Francis Inc.
N1  - Cited By :2
N1  - Export Date: 18 November 2019
M3  - Review
DB  - Scopus
C2  - 30704343
LA  - English
N1  - Correspondence Address: Zuhl, M.; Department of Health, Exercise, and Sports Sciences, University of New MexicoUnited States; email: zuhl09@unm.edu
N1  - Chemicals/CAS: brain derived neurotrophic factor, 218441-99-7; corticotropin, 11136-52-0, 9002-60-2, 9061-27-2; serotonin, 50-67-9
N1  - References: Sender, R., Fuchs, S., Milo, R., Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans (2016) Cell, 164 (3), pp. 337-340;
Chen, J., He, X., Huang, J., Diet effects in gut microbiome and obesity (2014) J Food Sci, 79, p. 4;
Peters, H., De Vries, W., Vanberge-Henegouwen, G., Akkermans, L., Potential benefits and hazards of physical activity and exercise on the gastrointestinal tract (2001) Gut, 48, pp. 435-439;
Mach, N., Fuster-Botella, D., Endurance exercise and gut microbiota: A review (2017) J Sport Health Sci, 6 (2), pp. 179-197;
Cronin, O., Molloy, M.G., Shanahan, F., Exercise, fitness, and the gut (2016) Curr Opin Gastroenterol, 32 (2), pp. 67-73;
Bermon, S., Petriz, B., Kajeniene, A., Prestes, J., Castell, L., Franco, O.L., The microbiota: an exercise immunology perspective (2015) Exerc Immunol Rev, 21, p. 9;
Sharon, G., Sampson, T.R., Geschwind, D.H., Mazmanian, S.K., The central nervous system and the gut microbiome (2016) Cell, 167 (4), pp. 915-932;
Proctor, C., Thiennimitr, P., Chattipakorn, N., Chattipakorn, S.C., Diet, gut microbiota and cognition (2017) Metab Brain Dis, 32 (1), pp. 1-17;
Foster, J.A., Rinaman, L., Cryan, J.F., Stress & the gut-brain axis: regulation by the microbiome (2017) Neurobiol Stress, 7, pp. 124-136;
Clark, A., Mach, N., Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes (2016) J Int Soc Sports Nutr, 13, p. 43;
Burokas, A., Arboleya, S., Moloney, R.D., Peterson, V.L., Murphy, K., Clarke, G., Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice (2017) Biol Psychiatry, 82 (7), pp. 472-487. , Stanton C, Dinan TG, Cryan JF;
Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., Tóth, M., Korecka, A., Guan, N.L., The gut microbiota influences blood-brain barrier permeability in mice (2014) Sci Transl Med, 6 (263), p. 263ra158;
Wong, J.M., de Souza, R., Kendall, C.W., Emam, A., Jenkins, D.J., Colonic health: fermentation and short chain fatty acids (2006) J Clin Gastroenterol, 40, pp. 235-243;
Lin, H.V., Frassetto, A., Kowalik, E.J., Jr., Nawrocki, A.R., Lu, M.M., Kosinski, J.R., Hubert, J.A., Forrest, G., Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms (2012) PLoS One, 7 (4);
Tang, W.W., Wang, Z., Levison, B.S., Koeth, R.A., Britt, E.B., Fu, X., Wu, Y., Hazen, S.L., Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk (2013) N Engl J Med, 368 (17), pp. 1575-1584;
Kelly, D., Campbell, J.I., King, T.P., Grant, G., Jansson, E.A., Coutts, A.G., Pettersson, S., Conway, S., Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA (2004) Nat Immunol, 5 (1), p. 104;
Goodrich, J.K., Waters, J.L., Poole, A.C., Sutter, J.L., Koren, O., Blekhman, R., Beaumont, M., Bell, J.T., Human genetics shape the gut microbiome (2014) Cell, 159 (4), pp. 789-799;
Mariat, D., Firmesse, O., Levenez, F., Guimarăes, V., Sokol, H., Doré, J., Corthier, G., Furet, J.-P., The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age (2009) BMC Microbiol, 9 (1), p. 123;
Conlan, S., Kong, H.H., Segre, J.A., Species-level analysis of DNA sequence data from the NIH human microbiome project (2012) PLoS One, 7 (10);
Group, N.H.W., Peterson, J., Garges, S., Giovanni, M., McInnes, P., Wang, L., Schloss, J.A., Wetterstrand, K.A., The NIH human microbiome project (2009) Genome Res, 19 (12), pp. 2317-2323;
Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota (2012) Nature, 489 (7415), p. 220;
Hartstra, A.V., Bouter, K.E., Bäckhed, F., Nieuwdorp, M., Insights into the role of the microbiome in obesity and type 2 diabetes (2015) Diabetes Care, 38 (1), pp. 159-165;
Li, D., Kirsop, J., Tang, W.W., Listening to our gut: contribution of gut microbiota and cardiovascular risk in diabetes pathogenesis (2015) Curr Diab Rep, 15 (9), p. 63;
Dinan, T.G., Cryan, J.F., Melancholic microbes: a link between gut microbiota and depression? (2013) Neurogastroenterol Motil, 25 (9), pp. 713-719;
Cani, P.D., Delzenne, N.M., Involvement of the gut microbiota in the development of low grade inflammation associated with obesity: focus on this neglected partner (2010) Acta Gastroenterol Belg, 73, pp. 267-269;
Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., Geurts, L., Lambert, D.M., Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability (2009) Gut, 58 (8), pp. 1091-1103;
Everard, A., Lazarevic, V., Derrien, M., Girard, M., Muccioli, G.G., Neyrinck, A.M., Neyrinck, A.M., François, P., Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice (2011) Diabetes, 60 (11), pp. 2775-2786;
Mayer, E.A., Gut feelings: the emerging biology of gut–brain communication (2011) Nat Rev Neurosci, 12 (8), p. 453;
Kennedy, P., Clarke, G., O‘Neill, A., Groeger, J., Quigley, E., Shanahan, F., Cryan, J.F., Dinan, T.G., Cognitive performance in irritable bowel syndrome: evidence of a stress-related impairment in visuospatial memory (2014) Psychol Med, 44 (7), pp. 1553-1566;
Kennedy, P.J., Cryan, J.F., Dinan, T.G., Clarke, G., Irritable bowel syndrome: a microbiome-gut-brain axis disorder? (2014) World J Gastroenterol, 20 (39), p. 14105;
Castanon, N., Lasselin, J., Capuron, L., Neuropsychiatric comorbidity in obesity: role of inflammatory processes (2014) Front Endocrinol (Lausanne), 5, p. 74;
Lackner, J.M., Ma, C.X., Keefer, L., Brenner, D.M., Gudleski, G.D., Satchidanand, N., Firth, R., Krasner, S.S., Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome (2013) Clin Gastroenterol Hepatol, 11 (9), pp. 1147-1157;
Thorkelson, G., Bielefeldt, K., Szigethy, E., Empirically supported use of psychiatric medications in adolescents and adults with IBD (2016) Inflamm Bowel Dis, 22 (6), pp. 1509-1522;
Cryan, J.F., O’mahony, S., The microbiome‐gut‐brain axis: from bowel to behavior (2011) Neurogastroenterol Motil, 23 (3), pp. 187-192;
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Cazaubiel, M., Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects (2011) Br J Nutr, 105 (5), pp. 755-764;
Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition (2007) Eur J Clin Nutr, 61 (3), p. 355;
Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., Dinan, T.G., The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat (2008) J Psychiatr Res, 43 (2), pp. 164-174;
Hoveyda, N., Heneghan, C., Mahtani, K.R., Perera, R., Roberts, N., Glasziou, P., A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome (2009) BMC Gastroenterol, 9 (1), p. 15;
Ringel, Y., Quigley, E.M., Lin, H.C., Using probiotics in gastrointestinal disorders (2012) Am J Gastroenterol Suppl, 1 (1), p. 34;
Colcombe, S.J., Erickson, K.I., Scalf, P.E., Kim, J.S., Prakash, R., McAuley, E., Elavsky, S., Kramer, A.F., Aerobic exercise training increases brain volume in aging humans (2006) J Gerontol A Biol Sci Med Sci, 61 (11), pp. 1166-1170;
Gomez‐Pinilla, F., Hillman, C., The influence of exercise on cognitive abilities Compr Physiol, , 2013;3(1):403–428;
Clarke, S.F., Murphy, E.F., O’sullivan, O., Lucey, A.J., Humphreys, M., Hogan, A., Exercise and associated dietary extremes impact on gut microbial diversity (2014) Gut, pp. 1913-1920. , 63(12;
Mika, A., Van Treuren, W., González, A., Herrera, J.J., Knight, R., Fleshner, M., Exercise is more effective at altering gut microbial composition and producing stable changes in lean mass in juvenile versus adult male F344 rats (2015) PLoS One, 10 (5);
Welly, R.J., Liu, T.-W., Zidon, T.M., Rowles, J.L., III, Park, Y.-M., Smith, T.N., Swanson, K.S., Vieira-Potter, V.J., Comparison of diet vs. exercise on metabolic function & gut microbiota in obese rats (2016) Med Sci Sports Exerc, 48 (9), p. 1688;
Monda, V., Villano, I., Messina, A., Valenzano, A., Esposito, T., Moscatelli, F., Viggiano, A., Monda, M., Exercise modifies the gut microbiota with positive health effects (2017) Oxid Med Cell Longev, 2017;
Clarke, G., Dinan, T., Cryan, J., Microbiome–gut–brain Axis (2015) Encyclopedia of metagenomics: environmental metagenomics, pp. 425-437. , Highlander S.K., Rodriguez-Valera F., White B.A., (eds), Boston (MA): Springer US,. In:, editors.,. p;
Grenham, S., Clarke, G., Cryan, J.F., Dinan, T.G., Brain–gut–microbe communication in health and disease (2011) Front Physiol, 2, p. 94;
Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour (2012) Nat Rev Neurosci, 13 (10), p. 701;
Forsythe, P., Kunze, W., Bienenstock, J., Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis? (2016) BMC Med, 14 (1), p. 58;
Brookes, S.J., Spencer, N.J., Costa, M., Zagorodnyuk, V.P., Extrinsic primary afferent signalling in the gut (2013) Nat Rev Gastroenterol Hepatol, 10 (5), p. 286;
Forsythe, P., Kunze, W.A., Bienenstock, J., On communication between gut microbes and the brain (2012) Curr Opin Gastroenterol, 28 (6), pp. 557-562;
Forsythe, P., Bienenstock, J., Kunze, W.A., Vagal pathways for microbiome-brain-gut axis communication (2014) Microbial endocrinology: the microbiota-gut-brain axis in health and disease, pp. 115-133. , In:,. Adv Exp Med Biol.,;817;
Pellissier, S., Dantzer, C., Mondillon, L., Trocme, C., Gauchez, A.-S., Ducros, V., Mathieu, N., Canini, F., Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn’s disease and irritable bowel syndrome (2014) PLoS One, 9 (9);
Liu, Q., Wang, E.M., Yan, X.J., Chen, S.L., Autonomic functioning in irritable bowel syndrome measured by heart rate variability: A meta‐analysis (2013) J Dig Dis, 14 (12), pp. 638-646;
Malick, M., Gilbert, K., Daniel, J., Arseneault‐Breard, J., Tompkins, T., Godbout, R., Rousseau, G., Vagotomy prevents the effect of probiotics on caspase activity in a model of postmyocardial infarction depression (2015) Neurogastroenterol Motil, 27 (5), pp. 663-671;
Li, S., Zhai, X., Rong, P., McCabe, M.F., Wang, X., Zhao, J., Ben, H., Slattery, D.A., Therapeutic effect of vagus nerve stimulation on depressive-like behavior, hyperglycemia and insulin receptor expression in Zucker fatty rats (2014) PLoS One, 9 (11);
Grimonprez, A., Raedt, R., Baeken, C., Boon, P., Vonck, K., The antidepressant mechanism of action of vagus nerve stimulation: evidence from preclinical studies (2015) Neurosci Biobehav Rev, 56, pp. 26-34;
Kheder, S.H., Heller, J., Bär, J., Wutzler, A., Menge, B., Juckel, G., Autonomic dysfunction of gastric motility in major depression (2018) J Affect Disord, 226, pp. 196-202;
Bercik, P., Park, A., Sinclair, D., Khoshdel, A., Lu, J., Huang, X., Deng, Y., Moine, D., The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut–brain communication (2011) Neurogastroenterol Motil, 23 (12), pp. 1132-1139;
Tsigos, C., Chrousos, G.P., Hypothalamic–pituitary–adrenal axis, neuroendocrine factors and stress (2002) J Psychosom Res, 53, pp. 865-871;
Farzi, A., Fröhlich, E.E., Holzer, P., Gut microbiota and the neuroendocrine system (2018) Neurotherapeutics, pp. 15(1):1-18;
Hosoi, T., Okuma, Y., Matsuda, T., Nomura, Y., Novel pathway for LPS-induced afferent vagus nerve activation: possible role of nodose ganglion (2005) Auton Neurosci: Basic Clin, 120 (1), pp. 104-107;
Dinan, T.G., Quigley, E.M., Ahmed, S.M., Scully, P., O’Brien, S., O’Mahony, L., O’Mahony, S., Keeling, P.W.N., Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? (2006) Gastroenterology, 130 (2), pp. 304-311;
Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., Kubo, C., Koga, Y., Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice (2004) J Physiol, 558 (1), pp. 263-275;
O’Mahony, S., Clarke, G., Borre, Y., Dinan, T., Cryan, J., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis (2015) Behav Brain Res, 277, pp. 32-48;
Bressa, C., Bailén-Andrino, M., Pérez-Santiago, J., González-Soltero, R., Pérez, M., Montalvo-Lominchar, M.G., Maté-Muñoz, J.L., Larrosa, M., Differences in gut microbiota profile between women with active lifestyle and sedentary women (2017) PLoS One, 12 (2);
Schecterson, L.C., Bothwell, M., Novel roles for neurotrophins are suggested by BDNF and NT-3 mRNA expression in developing neurons (1992) Neuron, 9, pp. 449-463;
Li, C., Cai, Y.-Y., Yan, Z.-X., Brain-derived neurotrophic factor preserves intestinal mucosal barrier function and alters gut microbiota in mice (2018) Kaohsiung J Med Sci, 34 (3), pp. 134-141;
Bravo, J.A., Julio-Pieper, M., Forsythe, P., Kunze, W., Dinan, T.G., Bienenstock, J., Cryan, J.F., Communication between gastrointestinal bacteria and the nervous system (2012) Curr Opin Pharmacol, 12 (6), pp. 667-672;
von Boyen, G.B., Reinshagen, M., Steinkamp, M., Adler, G., Kirsch, J., Enteric nervous plasticity and development: dependence on neurotrophic factors (2002) J Gastroenterol, 37 (8), pp. 583-588;
Heijtz, R.D., Wang, S., Anuar, F., Qian, Y., Björkholm, B., Samuelsson, A., Hibberd, M.L., Pettersson, S., Normal gut microbiota modulates brain development and behavior (2011) Proc Natl Acad Sci, 108 (7), pp. 3047-3052;
Jenkins, T.A., Nguyen, J.C., Polglaze, K.E., Bertrand, P.P., Influence of tryptophan and serotonin on mood and cognition with a possible role of the gut-brain axis (2016) Nutrients, 8 (1), p. 56;
Young, S.N., How to increase serotonin in the human brain without drugs (2007) J Psychol Psychiatr Neuroscil, 32, p. 394;
Gershon, M.D., Tack, J., The serotonin signaling system: from basic understanding to drug development for functional GI disorders (2007) Gastroenterology, 132 (1), pp. 397-414;
Mawe, G.M., Hoffman, J.M., Serotonin signalling in the gut—functions, dysfunctions and therapeutic targets (2013) Nat Rev Gastroenterol Hepatol, 10 (8), p. 473;
Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Hsiao, E.Y., Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis (2015) Cell, 161 (2), pp. 264-276;
Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R., Shanahan, F., Dinan, T.G., Cryan, J.F., The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner (2013) Mol Psychiatry, 18 (6), p. 666;
Yanofsky, C., RNA-based regulation of genes of tryptophan synthesis and degradation, in bacteria (2007) Rna, 13 (8), pp. 1141-1154;
Strasser, B., Gostner, J.M., Fuchs, D., Mood, food, and cognition: role of tryptophan and serotonin (2016) Curr Opin Clin Nutr Metab Care, 19 (1), pp. 55-61;
Ochoa-Reparaz, J., Mielcarz, D., Wang, Y., Begum-Haque, S., Dasgupta, S., Kasper, D., A polysaccharide from the human commensal bacteroides fragilis protects against CNS demyelinating disease (2010) Mucosal Immunol, 3 (5), p. 487. , Kasper L;
Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., Codelli, J.A., Petrosino, J.F., Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders (2013) Cell, 155 (7), pp. 1451-1463;
Yunes, R., Poluektova, E., Dyachkova, M., Klimina, K., Kovtun, A., Averina, O., Orlova, V.S., Danilenko, V.N., GABA production and structure of gadB/gadC genes in lactobacillus and bifidobacterium strains from human microbiota (2016) Anaerobe, 42, pp. 197-204;
Asano, Y., Hiramoto, T., Nishino, R., Aiba, Y., Kimura, T., Yoshihara, K., Koga, Y., Sudo, N., Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice (2012) Am J Physiol Gastrointest Liver Physiol, 303 (11), pp. G1288-G1295;
Zuhl, M., Dokladny, K., Mermier, C., Schneider, S., Salgado, R., Moseley, P., The effects of acute oral glutamine supplementation on exercise-induced gastrointestinal permeability and heat shock protein expression in peripheral blood mononuclear cells (2015) Cell Stress Chaperones, 20 (1), pp. 85-93;
Lambert, G.P., Intestinal barrier dysfunction, endotoxemia, and gastrointestinal symptoms: the ‘canary in the coal mine’during exercise-heat stress? (2008) Thermoregulation and human performance, pp. 61-73. , Med Sport Sci,. In:,;53;
Dokladny, K., Zuhl, M.N., Moseley, P.L., Intestinal epithelial barrier function and tight junction proteins with heat and exercise (2015) J Appl Physiol, 120 (6), pp. 692-701;
Johannesson, E., Simrén, M., Strid, H., Bajor, A., Sadik, R., Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial (2011) Am J Gastroenterol, 106 (5), p. 915;
Wu, M.H., Lee, C.P., Hsu, S.C., Chang, C.M., Chen, C.Y., Effectiveness of high-intensity interval training on the mental and physical health of people with chronic schizophrenia (2015) Neuropsychiatr Dis Treat, 11, p. 1255;
McNeil, J.K., LeBlanc, E.M., Joyner, M., The effect of exercise on depressive symptoms in the moderately depressed elderly (1991) Psychol Aging, 6 (3), p. 487;
Quaney, B.M., Boyd, L.A., McDowd, J.M., Zahner, L.H., He, J., Mayo, M.S., Macko, R.F., Aerobic exercise improves cognition and motor function poststroke (2009) Neurorehab Neural Repar, 23 (9), pp. 879-885;
Jeffery, I.B., O’toole, P.W., Öhman, L., Claesson, M.J., Deane, J., Quigley, E.M., Simrén, M., An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota (2012) Gut, 61 (7), pp. 997-1006;
Kajander, K., Myllyluoma, E., Rajilić‐Stojanović, M., Kyrönpalo, S., Rasmussen, M., Järvenpää, S., Zoetendal, E.G., Korpela, R., Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) Aliment Pharmacol Ther, 27 (1), pp. 48-57;
Choi, C.H., Jo, S.Y., Park, H.J., Chang, S.K., Byeon, J.-S., Myung, S.-J., A randomized, double-blind, placebo-controlled multicenter trial of Saccharomyces boulardii in irritable bowel syndrome: effect on quality of life (2011) J Clin Gastroenterol, 45 (8), pp. 679-683;
Diop, L., Guillou, S., Durand, H., Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: a double-blind, placebo-controlled, randomized trial (2008) Nutr Res, 28 (1), pp. 1-5;
McFadzean, R., (2014) Exercise can help modulate human gut microbiota, , CU Scholar.,. Undergraduate honors thesis 155;
Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Delzenne, N.M., Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity (2013) Proc Natl Acad Sci USA, 110 (22), pp. 9066-9071;
Noble, E.E., Hsu, T.M., Kanoski, S.E., Gut to brain dysbiosis: mechanisms linking western diet consumption, the microbiome, and cognitive impairment (2017) Front Behav Neurosci, 11, p. 9;
Bruce-Keller, A.J., Salbaum, J.M., Luo, M., Blanchard, E., IV, Taylor, C.M., Welsh, D.A., Berthoud, H.-R., Obese-type gut microbiota induce neurobehavioral changes in the absence of obesity (2015) Biol Psychiatry, 77 (7), pp. 607-615;
Barton, W., Penney, N.C., Cronin, O., Garcia-Perez, I., Molloy, M.G., Holmes, E., Shanahan, F., O’Sullivan, O., The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level (2018) Gut, 67 (4), pp. 625-633;
Macfarlane, G.T., Macfarlane, S., Bacteria, colonic fermentation, and gastrointestinal health (2012) J AOAC Int, 95, pp. 50-60;
Estaki, M., Pither, J., Baumeister, P., Little, J.P., Gill, S.K., Ghosh, S., Ahmadi-Vand, Z., Gibson, D.L., Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions (2016) Microbiome, 4 (1), p. 42;
Ohira, H., Tsutsui, W., Fujioka, Y., Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis? (2017) J Atheroscler Thromb, 24 (7), pp. 660-672;
Erny, D., Hrabe de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Buch, T., Host microbiota constantly control maturation and function of microglia in the CNS (2015) Nat Neurosci, 18 (7), pp. 965-977;
Kang, S.S., Jeraldo, P.R., Kurti, A., Miller, M.E.B., Cook, M.D., Whitlock, K., Goldenfeld, N., Chia, N., Diet and exercise orthogonally alter the gut microbiome and reveal independent associations with anxiety and cognition (2014) Mol Neurodegener, 9 (1), p. 36;
Evans, C.C., LePard, K.J., Kwak, J.W., Stancukas, M.C., Laskowski, S., Dougherty, J., Moulton, L., Leone, V., Exercise prevents weight gain and alters the gut microbiota in a mouse model of high fat diet-induced obesity (2014) PLoS One, 9 (3);
Ley, R.E., Turnbaugh, P.J., Klein, S., Gordon, J.I., Microbial ecology: human gut microbes associated with obesity (2006) Nature, 444 (7122), pp. 1022-1023;
Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., Almeida, M., Kennedy, S., Richness of human gut microbiome correlates with metabolic markers (2013) Nature, 500 (7464), pp. 541-546;
Queipo-Ortuño, M.I., Seoane, L.M., Murri, M., Pardo, M., Gomez-Zumaquero, J.M., Cardona, F., Casanueva, F., Sanz, Y., Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels (2013) PLoS One, 8 (5);
Barcenilla, A., Pryde, S.E., Martin, J.C., Duncan, S.H., Stewart, C.S., Henderson, C., Flint, H.J., Phylogenetic relationships of butyrate-producing bacteria from the human gut (2000) Appl Environ Microbiol, 66, pp. 1654-1661;
Boakes, R.A., Self-starvation in the rat: running versus eating (2007) Span J Psychol, 10, pp. 251-257;
Zhao, X., Zhang, Z., Hu, B., Huang, W., Yuan, C., Zou, L., Response of gut microbiota to metabolite changes induced by endurance exercise (2018) Front Microbiol, 9, p. 765;
Martinez, I., Wallace, G., Zhang, C., Legge, R., Benson, A.K., Carr, T.P., Moriyama, E.N., Walter, J., Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota (2009) Appl Environ Microbiol, 75 (12), pp. 4175-4184;
Liu, H., Zhang, H., Wang, X., Yu, X., Hu, C., Zhang, X., The family Coriobacteriaceae is a potential contributor to the beneficial effects of Roux-en-Y gastric bypass on type 2 diabetes (2018) Surg Obes Relat Dis, 14 (5), pp. 584-593;
Allen, J.M., Mailing, L.J., Niemiro, G.M., Moore, R., Cook, M.D., White, B.A., Holscher, H.D., Woods, J.A., Exercise alters gut microbiota composition and function in lean and obese humans (2018) Med Sci Sports Exerc, 50, pp. 747-757;
Donohoe, D.R., Garge, N., Zhang, X., Sun, W., O’Connell, T.M., Bunger, M.K., Bultman, S.J., The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon (2011) Cell Metab, 13 (5), pp. 517-526;
M Astbury, S., Corfe, B.M., Uptake and metabolism of the short-chain fatty acid butyrate, a critical review of the literature (2012) Curr Drug Metab, 13, pp. 815-821;
Wolin, K.Y., Yan, Y., Colditz, G.A., Lee, I., Physical activity and colon cancer prevention: a meta-analysis (2009) Br J Cancer, 100 (4), p. 611;
Yoo, D.Y., Kim, W., Nam, S.M., Kim, D.W., Chung, J.Y., Choi, S.Y., Synergistic effects of sodium butyrate, a histone deacetylase inhibitor, on increase of neurogenesis induced by pyridoxine and increase of neural proliferation in the mouse dentate gyrus (2011) Neurochem Res, 36 (10), p. 1850. , Yoon YS, Won MH, Hwang IK;
Kim, H.J., Leeds, P., Chuang, D.M., The HDAC inhibitor, sodium butyrate, stimulates neurogenesis in the ischemic brain (2009) J Neurochem, 110 (4), pp. 1226-1240;
Cronin, O., Barton, W., Skuse, P., Penney, N.C., Garcia-Perez, I., Murphy, E.F., Woods, T., Melgar, S., A prospective metagenomic and metabolomic analysis of the impact of exercise and/or whey protein supplementation on the gut microbiome of sedentary adults (2018) mSystems, 3 (3), pp. e00044-18;
Rottenberg, J., Cardiac vagal control in depression: a critical analysis (2007) Biol Psychol, 74 (2), pp. 200-211;
Gershon, M.D., Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome (2005) J Clin Gastroenterol, 39, pp. S184-S193;
Vempati, R., Telles, S., Yoga-based guided relaxation reduces sympathetic activity judged from baseline levels (2002) Psychol Rep, 90 (2), pp. 487-494;
Schumann, D., Anheyer, D., Lauche, R., Dobos, G., Langhorst, J., Cramer, H., Effect of yoga in the therapy of irritable bowel syndrome: a systematic review (2016) Clin Gastroenterol Hepatol, 14 (12), pp. 1720-1731;
Cramer, H., Lauche, R., Langhorst, J., Dobos, G., Yoga for depression: A systematic review and meta‐analysis (2013) Depress Anxiety, 30 (11), pp. 1068-1083;
Perez-Burgos, A., Wang, B., Mao, Y.-K., Mistry, B., Neufeld, K.-A.M., Bienenstock, J., Kunze, W., Psychoactive bacteria Lactobacillus rhamnosus (JB-1) elicits rapid frequency facilitation in vagal afferents (2012) Am J Physiol Gastrointest Liver Physiol, 304 (2), pp. G211-G220;
Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., Bienenstock, J., Cryan, J.F., Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve (2011) Proc Natl Acad Sci, 108 (38), pp. 16050-16055;
Colcombe, S., Kramer, A.F., Fitness effects on the cognitive function of older adults: a meta-analytic study (2003) Psychol Sci, 14 (2), pp. 125-130;
Kramer, A.F., Colcombe, S.J., McAuley, E., Scalf, P.E., Erickson, K.I., Fitness, aging and neurocognitive function (2005) Neurobiol Aging, 26 (1), pp. 124-127;
Rasmussen, P., Brassard, P., Adser, H., Pedersen, M.V., Leick, L., Hart, E., Secher, N.H., Pilegaard, H., Evidence for a release of brain‐derived neurotrophic factor from the brain during exercise (2009) Exp Physiol, 94 (10), pp. 1062-1069;
Molteni, R., Wu, A., Vaynman, S., Ying, Z., Barnard, R., Gomez-Pinilla, F., Exercise reverses the harmful effects of consumption of a high-fat diet on synaptic and behavioral plasticity associated to the action of brain-derived neurotrophic factor (2004) Neuroscience, 123, pp. 429-440;
Linnarsson, S., Björklund, A., Ernfors, P., Learning deficit in BDNF mutant mice (1997) Eur J Neurosci, 9, pp. 2581-2587;
Sarkar, A., Lehto, S.M., Harty, S., Dinan, T.G., Cryan, J.F., Burnet, P.W., Psychobiotics and the manipulation of bacteria–gut–brain signals (2016) Trends Neurosci, 39 (11), pp. 763-781;
Smith, F., Clark, J.E., Overman, B.L., Tozel, C.C., Huang, J.H., Rivier, J.E., Blikslager, A.T., Moeser, A.J., Early weaning stress impairs development of mucosal barrier function in the porcine intestine (2009) Am J Physiol Gastrointest Liver Physiol, 298 (3), pp. G352-G363;
Möhle, L., Mattei, D., Heimesaat, M.M., Bereswill, S., Fischer, A., Alutis, M., French, T., Dunay, I.R., Ly6Chi monocytes provide a link between antibiotic-induced changes in gut microbiota and adult hippocampal neurogenesis (2016) Cell Rep, 15 (9), pp. 1945-1956;
Cerdá, B., Pérez, M., Pérez-Santiago, J.D., Tornero-Aguilera, J.F., González-Soltero, R., Larrosa, M., Gut microbiota modification: another piece in the puzzle of the benefits of physical exercise in health? (2016) Front Physiol, 7, p. 51;
Cook, M.D., Martin, S.A., Williams, C., Whitlock, K., Wallig, M.A., Pence, B.D., Woods, J.A., Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis (2013) Brain Behav Immun, 33, pp. 46-56;
Lamoureux, E.V., Grandy, S.A., Langille, M.G.I., Moderate exercise has limited but distinguishable effects on the mouse microbiome (2017) mSystems, 2, p. 4;
Allen, J.M., Berg Miller, M.E., Pence, B.D., Whitlock, K., Nehra, V., Gaskins, H.R., White, B.A., Woods, J.A., Voluntary and forced exercise differentially alters the gut microbiome in C57BL/6J mice (2015) J Appl Physiol, 118 (8), pp. 1059-1066;
Lou De Santis, G., Kavvadia, M., Alwardat N, A.A.A., Bigioni, G., Zeppieri, C., Cascapera, S., Psychobiotics as integrative therapy for neuropsychiatric disorders with special emphasis on the microbiota-gut-brain axis (2017) Biomed Prev, 2, p. 111. , De Lorenzo A;
Dey, S., Singh, R., Dey, P., Exercise training: significance of regional alterations in serotonin metabolism of rat brain in relation to antidepressant effect of exercise (1992) Physiol Behav, 52, pp. 1095-1099;
Wipfli, B., Landers, D., Nagoshi, C., Ringenbach, S., An examination of serotonin and psychological variables in the relationship between exercise and mental health (2011) Scand J Med Sci Sports, 21 (3), pp. 474-481;
Özoğul, F., Kuley, E., Özoğul, Y., Özoğul, İ., The function of lactic acid bacteria on biogenic amines production by food-borne pathogens in arginine decarboxylase broth (2012) Food Sci Technol Res, 18 (6), pp. 795-804;
Özoğul, F., Production of biogenic amines by Morganella morganii, Klebsiella pneumoniae and Hafnia alvei using a rapid HPLC method (2004) Eur Food Res Technol, 219 (5), pp. 465-469
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072048782&doi=10.1080%2f19490976.2018.1562268&partnerID=40&md5=4c7474600eb607ef1a553797dfab8352
ER  -

TY  - JOUR
TI  - Role of brain imaging in disorders of brain-gut interaction: A Rome Working Team Report
T2  - Gut
J2  - Gut
VL  - 68
IS  - 9
SP  - 1701
EP  - 1715
PY  - 2019
DO  - 10.1136/gutjnl-2019-318308
SN  - 00175749 (ISSN)
AU  - Mayer, E.A.
AU  - Labus, J.
AU  - Aziz, Q.
AU  - Tracey, I.
AU  - Kilpatrick, L.
AU  - Elsenbruch, S.
AU  - Schweinhardt, P.
AU  - Van Oudenhove, L.
AU  - Borsook, D.
AD  - G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States
AD  - Neurogastroenterology Group, Queen Mary University of London, London, United Kingdom
AD  - Departments of Anaesthetics and Clinical Neurology, Pembroke College, Oxford, United Kingdom
AD  - Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg, Duisburg, Germany
AD  - Division of Biomedical Sciences, McGill University, Canada
AD  - Translational Research in GastroIntestinal Disorders, KU Leuven Department of Clinical and Experimental Medicine, University of Leuven, Leuven, Belgium
AD  - Center for Pain and the Brain, Boston Children's, Massachusetts General and McLean Hospitals, Harvard Medical School, Boston, MA, United States
AB  - Imaging of the living human brain is a powerful tool to probe the interactions between brain, gut and microbiome in health and in disorders of brain-gut interactions, in particular IBS. While altered signals from the viscera contribute to clinical symptoms, the brain integrates these interoceptive signals with emotional, cognitive and memory related inputs in a non-linear fashion to produce symptoms. Tremendous progress has occurred in the development of new imaging techniques that look at structural, functional and metabolic properties of brain regions and networks. Standardisation in image acquisition and advances in computational approaches has made it possible to study large data sets of imaging studies, identify network properties and integrate them with non-imaging data. These approaches are beginning to generate brain signatures in IBS that share some features with those obtained in other often overlapping chronic pain disorders such as urological pelvic pain syndromes and vulvodynia, suggesting shared mechanisms. Despite this progress, the identification of preclinical vulnerability factors and outcome predictors has been slow. To overcome current obstacles, the creation of consortia and the generation of standardised multisite repositories for brain imaging and metadata from multisite studies are required. © 2019 Author(s).
KW  - brain/gut interaction
KW  - functional bowel disorder
KW  - irritable bowel syndrome
KW  - magnetic resonance imaging
KW  - antihistaminic agent
KW  - cholinergic receptor blocking agent
KW  - cyproheptadine
KW  - muscarinic receptor blocking agent
KW  - serotonin antagonist
KW  - serotonin uptake inhibitor
KW  - tricyclic antidepressant agent
KW  - Article
KW  - brain disease
KW  - brain function
KW  - brain radiography
KW  - brain tissue
KW  - connectome
KW  - correlational study
KW  - drug mechanism
KW  - functional connectivity
KW  - gray matter
KW  - human
KW  - inflammatory bowel disease
KW  - neurobiology
KW  - neuroimaging
KW  - nuclear magnetic resonance imaging
KW  - nuclear magnetic resonance spectroscopy
KW  - pathophysiology
KW  - positron emission tomography
KW  - priority journal
KW  - standardization
KW  - tissue structure
KW  - brain
KW  - diagnostic imaging
KW  - irritable colon
KW  - nerve cell network
KW  - procedures
KW  - sexual characteristics
KW  - Big Data
KW  - Brain
KW  - Humans
KW  - Irritable Bowel Syndrome
KW  - Nerve Net
KW  - Neuroimaging
KW  - Sex Characteristics
PB  - BMJ Publishing Group
N1  - Cited By :2
N1  - Export Date: 18 November 2019
M3  - Article
DB  - Scopus
N1  - CODEN: GUTTA
C2  - 31175206
LA  - English
N1  - Correspondence Address: Mayer, E.A.; G. Oppenheimer Center for Neurobiology of Stress and Resilience, Vatche and Tamar Manoukian Division of Digestive Diseases, David Geffen School of Medicine, UCLAUnited States; email: emayer@ucla.edu
N1  - Chemicals/CAS: cyproheptadine, 129-03-3, 969-33-5
N1  - Funding details: National Institute of Diabetes and Digestive and Kidney Diseases, NIDDK, DK096606, DK064539, DK048351
N1  - Funding text 1: Acknowledgements EAM has been supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (DK048351, DK064539 and DK096606). Contributors EAM: study design, writing of individual sections and overall manuscript generation.JL: neuroimaging analysis. QA: planning of study; critical review of manuscript. IT: neurobiology of treatment effects. LK: sex differences. SE: Gaps in knowledge. PS: non-pharmacological interventions. LvO: PET imaging. DB: neurobiology of treatment effects. All coauthors: critical review of the entire manuscript.
N1  - References: Aziz, Q., Thompson, D.G., Brain-gut axis in health and disease (1998) Gastroenterology, 114, pp. 559-578;
Mayer, E.A., Gupta, A., Kilpatrick, L.A., Imaging brain mechanisms in chronic visceral pain (2015) Pain, 156, pp. S50-S63;
Drossman, D.A., Hasler, W.L., Rome IV-functional GI disorders: Disorders of gut-brain interaction (2016) Gastroenterology, 150, pp. 1257-1261;
Tillisch, K., Labus, J.S., Advances in imaging the brain-gut axis: Functional gastrointestinal disorders (2011) Gastroenterology, 140, pp. 407-411;
Van Oudenhove, L., Aziz, Q., Recent insights on central processing and psychological processes in functional gastrointestinal disorders (2009) Dig Liver Dis, 41, pp. 781-787;
Drossman, D.A., Functional gastrointestinal disorders: History, pathophysiology, clinical features, and Rome IV (2016) Gastroenterology, 150, pp. 1262-1279;
Mayer, E.A., Bushnell, M.C., Functional pain disorders: Time for a paradigm shift? (2009) Functional Pain Syndromes: Presentation and Pathophysiology, pp. 531-565. , Mayer EA, Bushnell MC, eds. Seattle: IASP Press;
Jones, M.P., Tack, J., Van Oudenhove, L., Mood and anxiety disorders precede development of functional gastrointestinal disorders in patients but not in the population (2017) Clin Gastroenterol Hepatol, 15, pp. 1014-1020;
Mayer, E.A., Labus, J.S., Tillisch, K., Towards a systems view of IBS (2015) Nat Rev Gastroenterol Hepatol, 12, pp. 592-605;
Tracey, I., Mantyh, P.W., The cerebral signature for pain perception and its modulation (2007) Neuron, 55, pp. 377-391;
Derbyshire, S.W.G., A systematic review of neuroimaging data during visceral stimulation (2003) Am J Gastroenterol, 98, pp. 12-20;
Tillisch, K., Mayer, E.A., Labus, J.S., Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome (2011) Gastroenterology, 140, pp. 91-100;
Al Omran, Y., Aziz, Q., Functional brain imaging in gastroenterology: To new beginnings (2014) Nat Rev Gastroenterol Hepatol, 11, pp. 565-576;
Enck, P., Aziz, Q., Barbara, G., Irritable bowel syndrome (2016) Nat Rev Dis Primers, 2, p. 16014;
Hobson, A.R., Aziz, Q., Brain imaging and functional gastrointestinal disorders: Has it helped our understanding? (2004) Gut, 53, pp. 1198-1206;
Aizawa, E., Sato, Y., Kochiyama, T., Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on FMRI and dynamic causal modeling (2012) Gastroenterology, 143, pp. 1188-1198;
Bajaj, S., Adhikari, B.M., Dhamala, M., Higher frequency network activity flow predicts lower frequency node activity in intrinsic low-frequency BOLD fluctuations (2013) PLoS One, 8;
Bullmore, E., Sporns, O., The economy of brain network organization (2012) Nat Rev Neurosci, 13, pp. 336-349;
Greicius, M.D., Supekar, K., Menon, V., Resting-state functional connectivity reflects structural connectivity in the default mode network (2009) Cereb Cortex, 19, pp. 72-78;
Guo, C.C., Kurth, F., Zhou, J., One-year test-retest reliability of intrinsic connectivity network fMRI in older adults (2012) Neuroimage, 61, pp. 1471-1483;
Hutchison, R.M., Womelsdorf, T., Gati, J.S., Resting-state connectivity identifies distinct functional networks in macaque cingulate cortex (2012) Cereb Cortex, 22, pp. 1294-1308;
Rubinov, M., Sporns, O., Complex network measures of brain connectivity: Uses and interpretations (2010) Neuroimage, 52, pp. 1059-1069;
Seeley, W.W., Menon, V., Schatzberg, A.F., Dissociable intrinsic connectivity networks for salience processing and executive control (2007) J Neurosci, 27, pp. 2349-2356;
Sporns, O., (2010) Networks of the Brain, , Cambridge, Massachussets: The MIT Press;
Bischoff, S.C., Barbara, G., Buurman, W., Intestinal permeability - A new target for disease prevention and therapy (2014) BMC Gastroenterol, 14, p. 189;
Drossman, D.A., Psychosocial and psychophysiologic mechanisms in GI illness (1994) The Growth of Gastroenterologic Knowledge in the 20th Century, pp. 419-432. , Kirsner JB, ed. Philadelphia: PA: Lea & Febiger;
Kennedy, P.J., Clarke, G., O'Neill, A., O'Neill, A., Cognitive performance in irritable bowel syndrome: Evidence of a stress-related impairment in visuospatial memory (2014) Psychol Med, 44, pp. 1553-1566;
Mayer, E.A., Savidge, T., Shulman, R.J., Brain-gut microbiome interactions and functional bowel disorders (2014) Gastroenterology, 146, pp. 1500-1512;
Piché, M., Arsenault, M., Poitras, P., Widespread hypersensitivity is related to altered pain inhibition processes in irritable bowel syndrome (2010) Pain, 148, pp. 49-58;
Wilder-Smith, C.H., The balancing act: Endogenous modulation of pain in functional gastrointestinal disorders (2011) Gut, 60, pp. 1589-1599;
Tijms, B.M., Seriès, P., Willshaw, D.J., Similarity-based extraction of individual networks from gray matter MRI scans (2012) Cereb Cortex, 22, pp. 1530-1541;
Barboza, J.L., Talley, N.J., Moshiree, B., Current and emerging pharmacotherapeutic options for irritable bowel syndrome (2014) Drugs, 74, pp. 1849-1870;
Hagmann, P., Kurant, M., Gigandet, X., Mapping human whole-brain structural networks with diffusion MRI (2007) PLoS One, 2;
Buckner, R.L., Andrews-Hanna, J.R., Schacter, D.L., The Brain's default network: Anatomy, function, and relevance to disease (2008) Ann N y Acad Sci, 1124, pp. 1-38;
Greicius, M.D., Krasnow, B., Reiss, A.L., Functional connectivity in the resting brain: A network analysis of the default mode hypothesis (2003) Proc Natl Acad Sci U S A, 100, pp. 253-258;
Mawe, G.M., Hoffman, J.M., Serotonin signalling in the gut-functions, dysfunctions and therapeutic targets (2013) Nat Rev Gastroenterol Hepatol, 10, pp. 473-486;
Bohórquez, D.V., Liddle, R.A., The gut connectome: Making sense of what you eat (2015) J Clin Invest, 125, pp. 888-890;
Farmer, A.D., Aziz, Q., Tack, J., The future of neuroscientific research in functional gastrointestinal disorders: Integration towards multidimensional (visceral) pain endophenotypes? (2010) J Psychosom Res, 68, pp. 475-481;
Fukudo, S., Stress and visceral pain: Focusing on irritable bowel syndrome (2013) Pain, 154, pp. S63-S70;
Hong, J.Y., Kilpatrick, L.A., Labus, J., Patients with chronic visceral pain show sex-related alterations in intrinsic oscillations of the resting brain (2013) J Neurosci, 33, pp. 11994-12002;
Kilpatrick, L.A., Ornitz, E., Ibrahimovic, H., Sex-related differences in prepulse inhibition of startle in irritable bowel syndrome (IBS) (2010) Biol Psychol, 84, pp. 272-278;
Van Oudenhove, L., Vandenberghe, J., Vos, R., Factors associated with co-morbid irritable bowel syndrome and chronic fatigue-like symptoms in functional dyspepsia (2011) Neurogastroenterol Motil, 23, pp. e202-e524;
Gupta, A., Kilpatrick, L., Labus, J., Early adverse life events and resting state neural networks in patients with chronic abdominal pain: Evidence for sex differences (2014) Psychosom Med, 76, pp. 404-412;
Naliboff, B.D., Berman, S., Suyenobu, B., Longitudinal change in perceptual and brain activation response to visceral stimuli in irritable bowel syndrome patients (2006) Gastroenterology, 131, pp. 352-365;
Gupta, A., Labus, J., Kilpatrick, L.A., Interactions of early adversity with stressrelated gene polymorphisms impact regional brain structure in females (2016) Brain Struct Funct, 221, pp. 1667-1679;
Orand, A., Gupta, A., Shih, W., Catecholaminergic gene polymorphisms are associated with GI symptoms and morphological brain changes in irritable bowel syndrome (2015) PLoS One, 10;
Berman, S., Suyenobu, B., Naliboff, B.D., Evidence for alterations in central noradrenergic signaling in irritable bowel syndrome (2012) Neuroimage, 63, pp. 1854-1863;
Gupta, A., Mayer, E.A., Bonyadi, M., NR3C1 and IL-1 polymorphisms interact with early adverse life events in influencing gray matter variations in women with and without chronic abdominal pain (2013) Society for Neuroscience, , San Diego, California, USA;
Kilpatrick, L.A., Labus, J.S., Coveleskie, K., The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome (2011) Gastroenterology, 140, pp. 1943-1951;
Gupta, A., Cole, S., Labus, J.S., Gene expression profiles in peripheral blood mononuclear cells correlate with salience network activity in chronic visceral pain: A pilot study (2017) Neurogastroenterol Motil, 29, p. e13027;
Labus, J.S., Oezguen, N., Hollister, E.B., 752 regional brain morphology Is associated with gut microbial metabolites in irritable bowel syndrome (IBS) (2015) Gastroenterology, 148, p. S142;
Clayton, J.A., Studying both sexes: A guiding principle for biomedicine (2016) Faseb J, 30, pp. 519-524;
Kilpatrick, L., Tillisch, K., (2012) Irritable Bowel Syndrome;
Gupta, A., Mayer, E.A., Fling, C., Sex-based differences in brain alterations across chronic pain conditions (2017) J Neurosci Res, 95, pp. 604-616;
Vincent, K., Tracey, I., Sex hormones and pain: The evidence from functional imaging (2010) Curr Pain Headache Rep, 14, pp. 396-403;
Vincent, K., Warnaby, C., Stagg, C.J., Brain imaging reveals that engagement of descending inhibitory pain pathways in healthy women in a low endogenous estradiol state varies with testosterone (2013) Pain, 154, pp. 515-524;
Melchior, M., Poisbeau, P., Gaumond, I., Insights into the mechanisms and the emergence of sex-differences in pain (2016) Neuroscience, 338, pp. 63-80;
Choi, J.C., Park, S.K., Kim, Y.H., Different brain activation patterns to pain and painrelated unpleasantness during the menstrual cycle (2006) Anesthesiology, 105, pp. 120-127;
Hg, L., Dupont, P., Geeraerts, B., Lack of endogenous opioid release during sustained visceral pain: A [11C]carfentanil PET study (2013) Pain, 154, pp. 2072-2077;
Jarcho, J.M., Feier, N.A., Bert, A., Diminished neurokinin-1 receptor availability in patients with two forms of chronic visceral pain (2013) Pain, 154, pp. 987-996;
Hg, L., Ceccarini, J., Weltens, N., Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia: A [F]MK-9470 PET study (2015) Psychother Psychosom, 84, pp. 149-158;
Tominaga, K., Tsumoto, C., Ataka, S., Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia (2015) Life Sci, 137, pp. 150-157;
Ende, G., Proton magnetic resonance spectroscopy: Relevance of glutamate and GABA to neuropsychology (2015) Neuropsychol Rev, 25, pp. 315-325;
Niddam, D.M., Tsai, S.Y., Lu, C.L., Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome: Preliminary findings using magnetic resonance spectroscopy (2011) Am J Gastroenterol, 106, pp. 1503-1511;
Labus, J.S., Dinov, I.D., Jiang, Z., Irritable bowel syndrome in female patients is associated with alterations in structural brain networks (2014) Pain, 155, pp. 137-149;
Labus, J.S., Hamadani, K., Gupta, A., Su1571 functional network properties of brain regions in irritable bowel syndrome (2016) Gastroenterology, 150, pp. S529-S529;
Labus, J.S., Van Horn, J.D., Torgerson, C., 585 architecture of anatomical brain networks differs in irritable bowel syndrome compared to healthy controls (2014) Gastroenterology, 146, pp. S-109;
Bullmore, E., Sporns, O., Complex brain networks: Graph theoretical analysis of structural and functional systems (2009) Nat Rev Neurosci, 10, pp. 186-198;
Sporns, O., Structure and function of complex brain networks (2013) Dialogues Clin Neurosci, 15, pp. 247-262;
Sporns, O., Network attributes for segregation and integration in the human brain (2013) Curr Opin Neurobiol, 23, pp. 162-171;
Labus, J.S., Naliboff, B., Kilpatrick, L., Pain and interoception imaging network (PAIN): A multimodal, multisite, brain-imaging repository for chronic somatic and visceral pain disorders (2016) Neuroimage, 124, pp. 1232-1237;
Dinov, I.D., Petrosyan, P., Liu, Z., The perfect neuroimaging-genetics-computation storm: Collision of petabytes of data, millions of hardware devices and thousands of software tools (2014) Brain Imaging Behav, 8, pp. 311-322;
Glasser, M.F., Sotiropoulos, S.N., Wilson, J.A., The minimal preprocessing pipelines for the human connectome project (2013) Neuroimage, 80, pp. 105-124;
(2013) Fact Sheet: BRAIN Initiative, , Secretary TWHOotP;
Markram, H., Human brain project: Henry markram plans to spend €1bn building a perfect model of the human brain (2013) Neuroscience Observer. The Guardian;
Van Essen, D.C., Smith, S.M., Barch, D.M., The WU-minn human connectome project: An overview (2013) Neuroimage, 80, pp. 62-79;
Allen, N., Sudlow, C., Downey, P., UK biobank: Current status and what it means for epidemiology (2012) Health Policy Technol, 1, pp. 123-126;
Guerreiro, R., Wojtas, A., Bras, J., TREM2 variants in Alzheimer's disease (2013) N Engl J Med, 368, pp. 117-127;
Swarup, V., Geschwind, D.H., Alzheimer's disease: From big data to mechanism (2013) Nature, 500, pp. 34-35;
Nalls, M.A., McLean, C.Y., Rick, J., Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: A population-based modelling study (2015) Lancet Neurol, 14, pp. 1002-1009;
Baliki, M.N., Petre, B., Torbey, S., Corticostriatal functional connectivity predicts transition to chronic back pain (2012) Nat Neurosci, 15, pp. 1117-1119;
Mansour, A.R., Baliki, M.N., Huang, L., Brain white matter structural properties predict transition to chronic pain (2013) Pain, 154, pp. 2160-2168;
Vachon-Presseau, E., Tétreault, P., Petre, B., Corticolimbic anatomical characteristics predetermine risk for chronic pain (2016) Brain, 139, pp. 1958-1970;
Denk, F., McMahon, S.B., Tracey, I., Pain vulnerability: A neurobiological perspective (2014) Nat Neurosci, 17, pp. 192-200;
Blankstein, U., Chen, J., Diamant, N.E., Altered brain structure in irritable bowel syndrome: Potential contributions of pre-existing and disease-driven factors (2010) Gastroenterology, 138, pp. 1783-1789;
Chen, J.Y., Blankstein, U., Diamant, N.E., White matter abnormalities in irritable bowel syndrome and relation to individual factors (2011) Brain Res, 1392, pp. 121-131;
Erpelding, N., Moayedi, M., Davis, K.D., Cortical thickness correlates of pain and temperature sensitivity (2012) Pain, 153, pp. 1602-1609;
Navratilova, E., Xie, J.Y., Meske, D., Endogenous opioid activity in the anterior cingulate cortex is required for relief of pain (2015) J Neurosci, 35, pp. 7264-7271;
Wanigasekera, V., Lee, M.C., Rogers, R., Baseline reward circuitry activity and trait reward responsiveness predict expression of opioid analgesia in healthy subjects (2012) Proc Natl Acad Sci U S A, 109, pp. 17705-17710;
Tracey, I., A vulnerability to chronic pain and its interrelationship with resistance to analgesia (2016) Brain, 139, pp. 1869-1872;
Harris, R.E., Napadow, V., Huggins, J.P., Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients (2013) Anesthesiology, 119, pp. 1453-1464;
Borsook, D., Hargreaves, R., Bountra, C., Lost but making progress-where will new analgesic drugs come from? (2014) Sci Transl Med, 249, p. sr3;
Camilleri, M., Review article: Biomarkers and personalised therapy in functional lower gastrointestinal disorders (2015) Aliment Pharmacol Ther, 42, pp. 818-828;
Erpelding, N., Simons, L., Lebel, A., Rapid treatment-induced brain changes in pediatric CRPS (2016) Brain Structure and Function, 221, pp. 1095-1111;
Becerra, L., Sava, S., Simons, L.E., Intrinsic brain networks normalize with treatment in pediatric complex regional pain syndrome (2014) Neuroimage, 6, pp. 347-369;
Gupta, A., Kilpatrick, L., Labus, J., Early adverse life events and resting state neural networks in patients with chronic abdominal pain (2014) Psychosom Med, 76, pp. 404-412;
Hong, J.-Y., Kilpatrick, L.A., Labus, J.S., Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain (2014) Journal of Neuroscience, 34, pp. 14252-14259;
Hubbard, C.S., Becerra, L., Heinz, N., Abdominal pain, the adolescent and altered brain structure and function (2016) PLoS One, 11;
Piché, M., Chen, J.I., Roy, M., Thicker posterior insula is associated with disease duration in women with irritable bowel syndrome (IBS) whereas thicker orbitofrontal cortex predicts reduced pain inhibition in both IBS patients and controls (2013) J Pain, 14, pp. 1217-1226;
Labus, J.S., Van Horn, J.D., Gupta, A., Multivariate morphological brain signatures predict patients with chronic abdominal pain from healthy control subjects (2015) Pain, 156, pp. 1545-1554;
Bourke, J.H., Wall, M.B., PhMRI: Methodological considerations for mitigating potential confounding factors (2015) Front Neurosci, 9, p. 167;
Jenkins, B.G., Pharmacologic magnetic resonance imaging (phMRI): Imaging drug action in the brain (2012) Neuroimage, 62, pp. 1072-1085;
Jacobs, B.L., Azmitia, E.C., Structure and function of the brain serotonin system (1992) Physiol Rev, 72, pp. 165-229;
Hubbard, C.S., Labus, J.S., Bueller, J., Corticotropin-releasing factor receptor 1 antagonist alters regional activation and effective connectivity in an emotional-arousal circuit during expectation of abdominal pain (2011) J Neurosci, 31, pp. 12491-12500;
Labus, J.S., Hubbard, C.S., Bueller, J., Impaired emotional learning and involvement of the corticotropin-releasing factor signaling system in patients with irritable bowel syndrome (2013) Gastroenterology, 145, pp. 1253-1261;
Berman, S.M., Chang, L., Suyenobu, B., Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist alosetron (2002) Gastroenterology, 123, pp. 969-977;
Mayer, E.A., Berman, S., Derbyshire, S.W., The effect of the 5-HT3 receptor antagonist, alosetron, on brain responses to visceral stimulation in irritable bowel syndrome patients (2002) Aliment Pharmacol Ther, 16, pp. 1357-1366;
Tillisch, K., Labus, J., Nam, B., Neurokinin-1-receptor antagonism decreases anxiety and emotional arousal circuit response to noxious visceral distension in women with irritable bowel syndrome: A pilot study (2012) Aliment Pharmacol Ther, 35, pp. 360-367;
Arrubla, J., Tse, D.H., Amkreutz, C., GABA concentration in posterior cingulate cortex predicts putamen response during resting state fMRI (2014) PLoS One, 9;
Cole, D.M., Beckmann, C.F., Oei, N.Y., Differential and distributed effects of dopamine neuromodulations on resting-state network connectivity (2013) Neuroimage, 78, pp. 59-67;
Cole, D.M., Beckmann, C.F., Searle, G.E., Orbitofrontal connectivity with resting-state networks is associated with midbrain dopamine D3 receptor availability (2012) Cereb Cortex, 22, pp. 2784-2793;
Cole, D.M., Oei, N.Y., Soeter, R.P., Dopamine-dependent architecture of corticosubcortical network connectivity (2013) Cereb Cortex, 23, pp. 1509-1516;
Van Den-Heuvel, M.P., Mandl, R.C., Kahn, R.S., Functionally linked resting-state networks reflect the underlying structural connectivity architecture of the human brain (2009) Hum Brain Mapp, 30, pp. 3127-3141;
Borsook, D., Erpelding, N., Becerra, L., Losses and gains: Chronic pain and altered brain morphology (2013) Expert Rev Neurother, 13, pp. 1221-1234;
Castrén, E., Hen, R., Neuronal plasticity and antidepressant actions (2013) Trends Neurosci, 36, pp. 259-267;
Castrén, E., Neuronal network plasticity and recovery from depression (2013) JAMA Psychiatry, 70, pp. 983-989;
Lackner, J.M., Lou Coad, M., Mertz, H.R., Cognitive therapy for irritable bowel syndrome is associated with reduced limbic activity, GI symptoms, and anxiety (2006) Behav Res Ther, 44, pp. 621-638;
Zhu, Y., Wu, Z., Ma, X., Brain regions involved in moxibustion-induced analgesia in irritable bowel syndrome with diarrhea: A functional magnetic resonance imaging study (2014) BMC Complement Altern Med, 14, p. 500;
Flor, H., Psychological pain interventions and neurophysiology: Implications for a mechanism-based approach (2014) Am Psychol, 69, pp. 188-196;
Jensen, K.B., Berna, C., Loggia, M.L., The use of functional neuroimaging to evaluate psychological and other non-pharmacological treatments for clinical pain (2012) Neurosci Lett, 520, pp. 156-164;
Harris, R.E., Zubieta, J.-K., Scott, D.J., Traditional Chinese acupuncture and placebo (sham) acupuncture are differentiated by their effects on μ-opioid receptors (MORs) (2009) Neuroimage, 47, pp. 1077-1085;
Egorova, N., Gollub, R.L., Kong, J., Repeated verum but not placebo acupuncture normalizes connectivity in brain regions dysregulated in chronic pain (2015) Neuroimage Clin, 9, pp. 430-435;
Dhond, R.P., Kettner, N., Napadow, V., Neuroimaging acupuncture effects in the human brain (2007) The Journal of Alternative and Complementary Medicine, 13, pp. 603-616;
Vanhaudenhuyse, A., Laureys, S., Faymonville, M.-E., Neurophysiology of hypnosis (2014) Neurophysiologie Clinique/Clinical Neurophysiology, 44, pp. 343-353;
Del Casale, A., Ferracuti, S., Rapinesi, C., Pain perception and hypnosis: Findings from recent functional neuroimaging studies (2015) Int J Clin Exp Hypn, 63, pp. 144-170;
Gaylord, S.A., Palsson, O.S., Garland, E.L., Mindfulness training reduces the severity of irritable bowel syndrome in women: Results of a randomized controlled trial (2011) Am J Gastroenterol, 106, pp. 1678-1688;
Ljótsson, B., Falk, L., Vesterlund, A.W., Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome-A randomized controlled trial (2010) Behav Res Ther, 48, pp. 531-539;
Larsson, M.B.O., Tillisch, K., Craig, A.D., Brain responses to visceral stimuli reflect visceral sensitivity thresholds in patients with irritable bowel syndrome (2012) Gastroenterology, 142, pp. 463-472;
Van Oudenhove, L., Vandenberghe, J., Dupont, P., Regional brain activity in functional dyspepsia: A H(2)(15)O-PET study on the role of gastric sensitivity and abuse history (2010) Gastroenterology, 139, pp. 36-47;
Elsenbruch, S., Rosenberger, C., Enck, P., Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome: An fMRI study (2010) Gut, 59, pp. 489-495;
Tillisch, K., Labus, J., Kilpatrick, L., Consumption of fermented milk product with probiotic modulates brain activity (2013) Gastroenterology, 144, pp. 1394-1401;
Tillisch, K., Mayer, E.A., Gupta, A., Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women (2017) Psychosom Med, 79, pp. 905-913;
Haroon, E., Fleischer, C.C., Felger, J.C., Conceptual convergence: Increased inflammation is associated with increased basal ganglia glutamate in patients with major depression (2016) Mol Psychiatry;
Čeko, M., Shir, Y., Ouellet, J.A., Partial recovery of abnormal insula and dorsolateral prefrontal connectivity to cognitive networks in chronic low back pain after treatment (2015) Hum Brain Mapp, 36, pp. 2075-2092;
Bräscher, A.K., Becker, S., Hoeppli, M.E., Different brain circuitries mediating controllable and uncontrollable pain (2016) J Neurosci, 36, pp. 5013-5025;
Keay, K.A., Bandler, R., Distinct central representations of inescapable and escapable pain: Observations and speculation (2002) Exp Physiol, 87, pp. 275-279;
Brown, G.K., Nicassio, P.M., Development of a questionnaire for the assessment of active and passive coping strategies in chronic pain patients (1987) Pain, 31, pp. 53-64;
Snow-Turek, A.L., Norris, M.P., Tan, G., Active and passive coping strategies in chronic pain patients (1996) Pain, 64, pp. 455-462;
Akassoglou, K., Merlini, M., Rafalski, V.A., In vivo imaging of CNS injury and disease (2017) J Neurosci, 37, pp. 10808-10816;
Greenwood-Van Meerveld, B., Prusator, D.K., Johnson, A.C., Animal models of gastrointestinal and liver diseases. Animal models of visceral pain: Pathophysiology, translational relevance, and challenges (2015) Am J Physiol Gastrointest Liver Physiol, 308, pp. G885-G903;
Holschneider, D.P., Bradesi, S., Mayer, E.A., The role of experimental models in developing new treatments for irritable bowel syndrome (2011) Expert Rev Gastroenterol Hepatol, 5, pp. 43-57;
Alger, J.R., Ellingson, B.M., Ashe-McNalley, C., Multisite, multimodal neuroimaging of chronic urological pelvic pain: Methodology of the MAPP research network (2016) Neuroimage, 12, pp. 65-77;
Landis, J.R., Williams, D.A., Lucia, M.S., The MAPP research network: Design, patient characterization and operations (2014) BMC Urol, 14, p. 58;
Clemens, J.Q., Mullins, C., Kusek, J.W., The MAPP research network: A novel study of urologic chronic pelvic pain syndromes (2014) BMC Urol, 14, p. 57;
Hong, J.Y., Kilpatrick, L.A., Labus, J.S., Sex and disease-related alterations of anterior insula functional connectivity in chronic abdominal pain (2014) J Neurosci, 34, pp. 14252-14259;
Hong, J.-Y., Naliboff, B.D., Labus, J.S., Sa2014 IBS patients show altered brain responses during uncertain, but not certain expectation of painful stimulation of the abdominal wall (2015) Gastroenterology, 148, p. S384;
Jiang, Z., Dinov, I.D., Labus, J., Sex-related differences of cortical thickness in patients with chronic abdominal pain (2013) PLoS One, 8;
Qi, R., Ke, J., Schoepf, U.J., Topological reorganization of the default mode network in irritable bowel syndrome (2016) Mol Neurobiol, 53, pp. 6585-6593;
Icenhour, A., Witt, S.T., Elsenbruch, S., Brain functional connectivity is associated with visceral sensitivity in women with irritable bowel syndrome (2017) Neuroimage, 15, pp. 449-457;
Ellingson, B.M., Mayer, E., Harris, R.J., Diffusion tensor imaging detects microstructural reorganization in the brain associated with chronic irritable bowel syndrome (2013) Pain, 154, pp. 1528-1541;
Mayer, E.A., Aziz, Q., Coen, S., Brain imaging approaches to the study of functional GI disorders: A Rome working team report (2009) Neurogastroenterol Motil, 21, pp. 579-596;
Hall, G.B., Kamath, M.V., Collins, S., Heightened central affective response to visceral sensations of pain and discomfort in IBS (2010) Neurogastroenterol Motil, 22, pp. e276-e280;
Elsenbruch, S., Rosenberger, C., Bingel, U., Patients with irritable bowel syndrome have altered emotional modulation of neural responses to visceral stimuli (2010) Gastroenterology, 139, pp. 1310-1319;
Labus, J.S., Gupta, A., Coveleskie, K., Sex differences in emotion-related cognitive processes in irritable bowel syndrome and healthy control subjects (2013) Pain, 154, pp. 2088-2099;
Berman, S., Munakata, J., Naliboff, B.D., Gender differences in regional brain response to visceral pressure in IBS patients (2000) Eur J Pain, 4, pp. 157-172;
Naliboff, B.D., Berman, S., Chang, L., Sex-related differences in IBS patients: Central processing of visceral stimuli (2003) Gastroenterology, 124, pp. 1738-1747;
Labus, J.S., Mayer, E.A., Jarcho, J., Acute tryptophan depletion alters the effective connectivity of emotional arousal circuitry during visceral stimuli in healthy women (2011) Gut, 60, pp. 1196-1203;
Straube, T., Schmidt, S., Weiss, T., Dynamic activation of the anterior cingulate cortex during anticipatory anxiety (2009) Neuroimage, 44, pp. 975-981;
Porro, C.A., Baraldi, P., Pagnoni, G., Does anticipation of pain affect cortical nociceptive systems? (2002) J Neurosci, 22, pp. 3206-3214;
Koyama, T., McHaffie, J.G., Laurienti, P.J., The subjective experience of pain: Where expectations become reality (2005) Proc Natl Acad Sci U S A, 102, pp. 12950-12955;
Bornhövd, K., Quante, M., Glauche, V., Painful stimuli evoke different stimulusresponse functions in the amygdala, prefrontal, insula and somatosensory cortex: A single-trial fMRI study (2002) Brain, 125, pp. 1326-1336;
Verne, G.N., Himes, N.C., Robinson, M.E., Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome (2003) Pain, 103, pp. 99-110;
Seifert, F., Schuberth, N., De Col, R., Brain activity during sympathetic response in anticipation and experience of pain (2013) Hum Brain Mapp, 34, pp. 1768-1782;
Yágüez, L., Coen, S., Gregory, L.J., Brain response to visceral aversive conditioning: A functional magnetic resonance imaging study (2005) Gastroenterology, 128, pp. 1819-1829;
Berman, S.M., Naliboff, B.D., Suyenobu, B., Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome (2008) J Neurosci, 28, pp. 349-359;
Stephan, E., Pardo, J.V., Faris, P.L., Functional neuroimaging of gastric distention (2003) J Gastrointest Surg, 7, pp. 740-749;
Lawal, A., Kern, M., Sanjeevi, A., Neurocognitive processing of esophageal central sensitization in the insula and cingulate gyrus (2008) Am J Physiol Gastrointest Liver Physiol, 294, pp. G787-G794;
Labus, J.S., Naliboff, B.N., Fallon, J., Sex differences in brain activity during aversive visceral stimulation and its expectation in patients with chronic abdominal pain: A network analysis (2008) Neuroimage, 41, pp. 1032-1043;
Rubio, A., Van Oudenhove, L., Pellissier, S., Uncertainty in anticipation of uncomfortable rectal distension is modulated by the autonomic nervous system - A fMRI study in healthy volunteers (2014) Neuroimage, 107 C, pp. 10-22;
Afzal, M., Potokar, J.P., Probert, C.S., Selective processing of gastrointestinal symptom-related stimuli in irritable bowel syndrome (2006) Psychosom Med, 68, pp. 758-761;
Gibbs-Gallagher, N., Palsson, O.S., Levy, R.L., Selective recall of gastrointestinalsensation words: Evidence for a cognitive-behavioral contribution to irritable bowel syndrome (2001) Am J Gastroenterol, 96, pp. 1133-1138;
Phillips, K., Wright, B.J., Kent, S., Irritable bowel syndrome and symptom severity: Evidence of negative attention bias, diminished vigour, and autonomic dysregulation (2014) J Psychosom Res, 77, pp. 13-19;
Tkalcic, M., Domijan, D., Pletikosic, S., Attentional biases in irritable bowel syndrome patients (2014) Clin Res Hepatol Gastroenterol, 38, pp. 621-628;
Labus, J.S., Naliboff, B.D., Berman, S.M., Brain networks underlying perceptual habituation to repeated aversive visceral stimuli in patients with irritable bowel syndrome (2009) Neuroimage, 47, pp. 952-960;
Seminowicz, D.A., Shpaner, M., Keaser, M.L., Cognitive-behavioral therapy increases prefrontal cortex gray matter in patients with chronic pain (2013) J Pain, 14, pp. 1573-1584;
Jeffery, I.B., O'Toole, P.W., Öhman, L., An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota (2012) Gut, 61, pp. 997-1006;
Simrén, M., IBS with intestinal microbial dysbiosis: A new and clinically relevant subgroup? (2014) Gut, 63, pp. 1685-1686;
Baliki, M.N., Schnitzer, T.J., Bauer, W.R., Brain morphological signatures for chronic pain (2011) PLoS One, 6;
Klöppel, S., Abdulkadir, A., Jack, C.R., Diagnostic neuroimaging across diseases (2012) Neuroimage, 61, pp. 457-463;
Rosa, M.J., Seymour, B., Decoding the matrix: Benefits and limitations of applying machine learning algorithms to pain neuroimaging (2014) Pain, 155, pp. 864-867
UR  - https://www.scopus.com/inward/record.uri?eid=2-s2.0-85068558935&doi=10.1136%2fgutjnl-2019-318308&partnerID=40&md5=93555339c7f7a251293a3e3cc5c51854
ER  -
